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ABSTRACT
The School of Graduate Studies
The University of Alabama in Huntsville
Degree: Doctor of Philosophy College/Dept.: Biotechnology Science and Engineering
Name of Candidate: Shristi Shrestha
Title: Comprehensive Functional and Transcriptome Analysis of Human Pancreatic islets
from Controls and Individuals with Type 1 Diabetic (T1D)
Type 1 Diabetes is chronic disease where immune moderated destruction of insulin
producing β cells disrupts normal glucose homeostasis in the body. Recent findings show
that few β cells remain in the pancreatic islets decades after disease onset challenging the
previous understanding that β cells are completely destroyed. Overcoming the limited
availability of T1D tissues, we studied functional and molecular features of pancreatic
islets from individuals with T1D and investigated the nature of the remaining β cells. We
found that remnant β cells have normal insulin secretory function and normally express
key transcription factor that regulates β cell function. On the other hand, glucagon
producing α cells, in normal physiology, counters insulin action and assist in producing
glucose from liver when glucose levels fall too low. However, in T1D patients,
counterregulatory response of glucagon is abnormal and exogenous insulin treatment can
sometimes induce hypoglycemic shock (low glucose). We found that remaining α cells in
pancreatic islets of T1D individuals had impaired glucagon secretion and expression of key
transcription factor important for normal α cell function were compromised. We propose a
model for disrupted α cell function based on our inspection of altered expression of genes
in T1D α cells that furthers our understanding of susceptibility to hypoglycemia in T1D.
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We further advanced the molecular characterization of pancreatic islets from normal
individuals through single cell resolution. Islets are highly multicellular where various cell
types collectively contribute to proper islet function. Efforts to purify each cell type and
investigate their transcriptional features has been challenging from flow cytometry
approach due lack of cell type specific markers and traditional single cell RNA-sequencing
approach has been low throughput compromising sensitivity. We applied a high throughput
approach on single cell RNA-sequencing to profile ~40,075 single cells from pancreatic
islets of healthy individuals. We obtained pure populations of all pancreatic cell types
based on transcriptional similarity and further identified transcriptional heterogeneity in β
and α cells highlighting their intrinsic properties of subpopulation and cellular states. With
this approach and findings about α and β cells subpopulations, we can further investigate
their changes at various age and diabetic state.
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Chapter 1
Background and Literature Review
Pancreatic islet architecture and function
Pancreas is a mixture of exocrine and endocrine tissue located behind the stomach and
connected to the spleen and duodenum. Exocrine tissue consists of acinar cells that secrete
digestive enzymes into a highly branched ductal system that are connected to the intestine,
where they facilitate food digestion (Edlund 2002; J. M. W. Slack 1995). The endocrine
tissue compartment represents only 1-2% of the pancreatic mass and is formed of small
cell clusters called Islets of Langerhans. Islets are dispersed throughout the pancreas and
produce hormones essential for regulation of blood glucose level. They are relatively
diverse in sizes ranging from 100-500µm and contain approximately 1000-3000 endocrine
cells per islet(Quesada et al. 2008). Islets are composed of five endocrine cell types with
insulin-secreting β cells and glucagon secreting α cells being the most abundant whereas
somatostatin-secreting δ cells, ghrelin-secreting ε cells and pancreatic polypeptidesecreting-PP (g) cells are rare (Figure 1.1) (Edlund 2002; Wierup et al. 2002).
Insulin and glucagon hormones are primarily responsible for maintaining the glucose
homeostasis. Rise in postprandial plasma glucose levels are sensed via various signals like
autonomic nerves and endocrine cells in gut and islets to subsequently stimulate insulin
production. The rise in insulin enhances glucose uptake in fat, liver and muscle tissue by
inducing translocation of glucose transporters in the plasma membrane of these cells.
Subsequently, the glucose uptake leads to glycogenesis in liver and muscles, and
triglyceride formation in adipose tissue. This process lowers circulating glucose
concentrations and in turn decreases insulin secretion. On the contrary, during
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hypoglycemia, glucagon is released from α cells to bind glucagon receptors in hepatocytes
triggering a signaling cascade to increase hepatic glucose production by glycogenolysis
and gluconeogenesis. Metabolic homeostasis in islets also involves intricate mediation
from brain through pancreatic innervation, which also communicates with insulin sensitive
organs such as liver, adipose tissue and muscle (Röder et al. 2016; Rosario et al. 2016)
(Figure 1.2)

Figure 1.1: Pancreatic
anatomy of exocrine and
endocrine tissue. a) The
pancreas is connected to
duodenum where pancreatic
ducts are linked to the bile
ducts. b) Acinar cells of the
exocrine pancreas produce the
digestive enzymes and
transported to the intestine by
pancreatic duct cells. c) Cell
types in islets are β, α, δ, ε and
PP cells. (ε cells are not
shown here). Image adapted
with permission from (Edlund
2002).

Figure 1.2: Interaction of
brain, liver, adipose,
muscle and pancreatic islet
tissues in maintaining
glucose homeostasis
through insulin, glucagon
hormones and
neuropeptides.
Image is courtesy of Marcela
Brissova, Vanderbilt
University.

2

The structural arrangement and composition of endocrine cell types in islets vary between
various species (Brissova 2005; Cabrera et al. 2006). Rodent islets have a β cell core
surrounded by mantle of non-β cells whereas in humans and non-human primates, β cells
are intermixed with δ and α cells throughout the islets( Cabrera et al. 2006; Bosco et al.
2010). In terms of composition, rodent islets mostly consist of β cells (75%) followed by
α cells (19%) and δ cells (6%). However, endocrine cell types in human islets vary
significantly in contrast to rodent islets (Figure 1.3)( Brissova 2005; Cabrera et al. 2006).
Such differences in cellular fractions have been speculated to be unaffected by age or sex
but β to α cell ratio can decrease with increasing BMI. (Blodgett et al. 2015)
A

B

C

D

Figure 1.3: Islet cell
organization and
composition differs
between species. Islet
cell type composition
analyzed in Mouse
(n=28) A) and Human
(n=32) B). Islets were
stained for hormones
insulin, green;
glucagon, red; and
somatostatin, blue. C)
Mouse and D) Human.
Image adapted with
permission from
Brissova et al. 2005.
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Physiology of insulin and glucagon secretion
Insulin is a small peptide hormone with two polypeptide chains. It is stored in secretory
granules of β cells after being converted from its precursor proinsulin in Golgi. Upon
glucose uptake through glucose transporter (GLUT-2 in rodents and primarily GLUT-1 in
humans)(McCulloch et al. 2011; De Vos et al. 1995) postprandial, glucose sensor of β cells,
glucokinase phosphorylates glucose to form glucose-6-phosphate entering glycolysis
followed by mitochondrial Krebs’ cycle producing NADH and FADH2 which is further
oxidatively metabolized through oxidative phosphorylation to generate ATP.
Consequently, elevated ATP:ADP ratio in the cytosol closes the ATP-sensitive K+ channel
(KATP), membrane protein constituting from subunits of sulphonylurea 1 receptor (SUR1)
and K+ channel pore forming subunit Kir6.2 (Figure 1.4). These KATP channel functions as
a mediator to integrate glucose energy in form of ATP and regulates β cell membrane
potential. Binding of ATP to Kir6.2 subunit of KATP channel leads to membrane
depolarization and opening of L-type voltage-dependent calcium (Ca2+) channel, allowing
the influx of Ca2+ into the cell. Increased intracellular Ca2+ triggers the movement of the
insulin secretory granules (β granules) and their fusion with plasma membrane through the
process called exocytosis. Events of insulin exocytosis such as priming of secretory
granules and their docking to the plasma membranes are regulated by soluble Nethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex.

Glucagon is a peptide composed of 29 amino acids synthesized and secreted from α cells
of pancreatic islets. Physiology of glucagon secretion is very similar to that of β cells in
that these cells share similarities in terms of their glucose sensing and hormone secretory
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machinery(Basco et al. 2018; Blodgett et al. 2015), however, important differences in their
utilization of this machinery impact cell function. Understanding of these differences is
currently a subject of intensive investigation. For example, it is unclear whether α cells can
intrinsically sense changes in glucose (Basco et al. 2018; Tengholm and Gylfe 2017) or
whether they rely primarily on paracrine signaling from adjacent β and d cells (Elliott et
al. 2015).

Figure 1.4: Steps of glucose
stimulated insulin secretion in β cells
showing KATP channels subunits,
SUR-1 and Kir6.2 (Inset). Schematic
adapted with permission from Bilous,
Rudy, and Richard Donnelly. "Diabetes
and Lifestyle." Handbook of Diabetes,
4th edition.

Islet vasculature and innervation
One of the characteristic features of islets is their dense capillary network surrounding the
endocrine cells (Figure 1.5). The intra-islet capillaries are known to be more dense and
tortuous in islets compared to exocrine tissue (Brissova et al. 2006; Reinert et al. 2013;
Chunhua Dai et al. 2013; Jansson et al. 2016). The endocrine pancreas relies on the highly
fenestrated vascular system for proper nutritional signals from the blood and have a direct
arterial supply that is 10 fold more than acinar tissues(Lammert 2001; Yoshitomi 2004;
Brissova et al. 2006; Reinert et al. 2013). This explains how b cells have an ability to
immediately sense blood glucose and rapidly secrete insulin into peripheral circulation.
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During pancreatic development, signals derived from endothelial cells are critical for
pancreatic morphogenesis and endocrine cell differentiation(Lammert et al. 2001;
Brissova et al. 2006; Magenheim et al. 2011; Cai et al. 2012; Cleaver et al. 2012). There
are species specific differences in islet vasculature(Virtanen et al. 2008), for example,
human islets have five-fold lesser intra-islet capillary density than mice( Brissova et al.
2014).
Additionally, islets are also richly innervated by autonomic nerves (sympathetic and
parasympathetic nervous systems) and sensory nerve fibers that regulates insulin and
glucagon secretion in response to signals originating from brain(Rodriguez-Diaz et al.
2012; Reinert et al. 2014). Axons reaching islets are closely aligned with intra-islet
capillaries and much more prominent in rodent than human islets(Rodriguez-Diaz and
Caicedo 2012; Reinert et al. 2014). The parasympathetic fibers in islets originate from
intrapancreatic ganglion and receive preganglionic input from vagus in brain. Release of
acetylcholine from these fibers stimulates the muscarinic receptors in b cell to potentiate
insulin secretion during hyperglycemia. In contrast, sympathetic nerves are known to
potentiate glucagon secretion by releasing neurotransmitters norepinephrine to increase
glucagon secretion during extreme hypoglycemia and increase glucose levels through
hepatic glucose production. Autonomic innervation also appears to be significant for
pancreatic islet structure and functional maturation (Dolensek et al. 2015).
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A.

B.

Figure 1.5: Pancreatic islet vasculature and innervation. A) Mouse Islet; insulin
(green), glucagon (blue) and endothelial marker CD31 (red). B) Human Islet; Insulin
(green), vascular marker, Type IV Collagen (purple) and pan-neuronal marker TUJ1
(red). Images are courtesy of Marcela Brissova, Vanderbilt University

Transcription factors regulating islet cell development and function
An elaborate transcriptional regulatory network governs the pancreatic cell differentiation
and maintains the mature endocrine, acinar and ductal cell phenotype. Our understanding
of processes and events taking place during pancreas development has mostly been
established through studies utilizing mouse models(Murtaugh 2006). Both exocrine and
endocrine cells are derived from a common progenitor originating in an embryonic foregut
endoderm. Pancreatic specification initiates with the expression of pancreatic and duodenal
homeobox 1 (PDX1) as early as 8.5 embryonic day in mouse (Figure 1.6A) (Murtaugh
2006) which becomes later enriched in b cells(Piccand et al. 2014; Smith et al. 2010).
Similarly, transcription factor PTF1A is expressed in the early pancreatic progenitor cells,
but later becomes restricted to acinar cells. Endocrine cell fate is determined by the
7

expression of basic helix-loop-helix factor neurogenin 3 (NGN3). NGN3 is key directly or
indirectly regulates downstream factors such as LIM homeobox protein islet-1 (Isl1),
paired box 4 and 6 (PAX4 and PAX6), aristaless related homeobox (ARX), NK6
homeobox (NKX6.1), NK2 homeobox 2 (NKX2.2), neuronal differentiation 1
(NEUROD1), regulatory factor X-box binding (RFX6) and others. Temporal pattern of
expression and combination of these factors further guide formation of five endocrine cell
types (Figure 1.6B) (reviewed in Pan and Wright 2011).Mechanisms of pancreatic
development in humans is still largely unclear due to limited availability of human fetal
and postnatal pancreas specimens. However, recent studies suggest that transcription
factors identified in early pancreatic differentiation are similar in mouse and humans
(reviewed in Marcela Brissova et al. 2006).
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Figure 1.6: Transcription factors critical for islet cell differentiation. A)
Transcription factors (in red) expressed in pancreatic progenitors of pancreatic cell
lineage. B) Transcription factors (in red) expressed in endocrine cell lineage. Image
adapted with permission from (Murtaugh 2006)

Diabetes mellitus
Diabetes mellitus is a chronic and heterogeneous disease caused by defect in glucose
regulation. Diabetes is the fifth most common cause of death in the world with 425 million
cases worldwide, predicted to rise to 693 million by the year 2045, with 352 million people
at high risk of developing diabetes (International Diabetes Federation Diabetes Atlas
2017) . In US alone, 30.2 million U.S. adults (9.4% of US population) had diabetes in 2015
(Center for Disease Control (CDC) 2017) . General categories of diabetes include type 1
diabetes (T1D), type 2 Diabetes (T2D), gestational diabetes mellitus (GDM) and mature
onset diabetes of the young (MODY) (American Diabetes Association 2017). T2D is the
most common form of diabetes accounting for 90% of cases and is prevalent but not limited
to older adults (International Diabetes Federation Diabetes Atlas 2017). The T2D is
mostly associated with poor diet and obesity causing progressive loss of β cell coupled
with insulin resistance. The GDM is characterized by diabetes diagnosed at the second or
third trimester of pregnancy and not observed before gestation. The MODY is a monogenic
form of diabetes. This thesis work, for the most part, focuses on understanding of the
pathophysiology of T1D, hence detailed discussion of other form of diabetes is not covered.
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Type 1 diabetes
T1D is a chronic metabolic disease mediated by autoimmune destruction of b cells leading
to loss of endogenous insulin secretion. Therefore, individuals with T1D must control their
blood glucose by administration of exogenous insulin via daily injections or more recently
by using insulin pumps. T1D is most common in young (0-19 years) Caucasian population
with approximately 132,600 new cases diagnosed every year ( Atkinson et al., 2014;
Atkinson, 2012). In addition, there is a geographical difference in global incidence of T1D
seen with a high prevalence in Scandinavian countries of Europe suggesting an influence
of an environmental factors on the disease development (Ziegler et al. 2013).

T1D pathophysiology
Combination of immune, genetic and environmental factors influencing the risk for T1D
appears to drive the immune system failure which ultimately leads to β cell destruction.
Major criteria of T1D diagnosis includes presentation of hyperglycaemia, high risk HLA
genotype and presence of autoantibodies directed against β cell proteins such as IAA
(insulin), GAD (glutamic acid decarboxylase), ZnT8A (zinc transporter 8), and IA2A
(insulinoma-associated autoantigen 2). For example, individuals with 2-4 autoantibodies
have nearly 80% chance of developing T1D by 20 years of age(Ziegler et al. 2013).
However, emergence of autoantibodies and progression from autoantibody positivity to
T1D onset varies between individuals on a scale of months to years but is shorter in very
young children compared to adults (Merger et al. 2013). The variable duration of
asymptomatic stage contributes to heterogeneity in clinical manifestation of T1D.
Additionally, not all autoantibody positive individuals proceed to develop T1D ( Knip et

10

al., 2010). Such variable disease progression has led to classification of T1D into several
stages by JDRF and American Diabetes Association (ADA) as illustrated in Figure
1.7(Storling and Brorsson 2013).

Figure 1.7: Standardized classification of T1D progression. Stage 1 is a
presymptomatic stage where patients who have two or more islet autoantibodies but
maintain normoglycemia. Stage 2 is also a presymptomatic state where patients develop
two or more islet autoantibodies but starts to establish glucose intolerance with gradual
b cell loss. Stage 3 is a symptomatic state where patients develop 2 or more islet
autoantibodies, high blood glucose and show clinical symptoms like polyuria, polydipsia,
polyphagis, weight loss and diabetic ketoacidosis associated to hyperglycaemic state.
Schematic adapted with permission from (Insel et al. 2015)

Because β cell mass cannot be clinically measured and pancreas cannot be safely biopsied,
we do not understand the time line of β cell loss in the presymptomatic and symptomatic
disease stage. However, the recent availability of pancreatic tissue for research by the
Network for Pancreatic Organ Donors with Diabetes (nPOD; (http://www.jdrfnpod.org)
made it possible to start getting insight into T1D disease process. Information emerging
from analyses of these tissues suggests that β cell mass is unchanged in individuals positive

11

for one or two autoantibodies (Campbell-Thompson et al. 2016; Rodriguez-Calvo et al.,
2017). In addition, several studies now show that small numbers of β cells persist and
secrete C-peptide in T1D patients, even after many years of disease duration(Oram et al.
2014; Keenan et al. 2010).

Althought islet α cells are speared by immune system, shortly after disease onset,
individuals with T1D develop two-fold glucagon secretory defect. During hypoglycemia,
they are unable to mount a counterregulatory glucagon secretory response (Gerich et al.
1973; Bolli et al. 1983), but at the same time they seem to secrete a relative excess of
glucagon in response to amino acid-mediated nutrient stimulation, which correlates with
progressive b cell loss (Gerich et al. 1975, Brown et al. 2008). The loss of glucagon
response to hypoglycemia is currently a major barrier to achieving adequate glycemic
control with exogeneous insulin therapy. Therefore, understanding the molecular
mechanisms of impaired glucagon secretion in T1D would provide unique insights into an
inherent α cell defect.

Genetic and immune factors in T1D
T1D is a polygenic disease where the inherited factor associated to T1D risk largely resides
in polymorphic HLA molecules. Both high risk and protective HLA genotypes exists
where mostly class II of MHC genes like DQ and DR alleles (DR3/4, DQB1*0201,
DQB1*0302) are associated with high risk for T1D whereas some alleles (DQB1*0602)
are associated with T1D resistance(Henquin et al., 2006). High-risk HLA genes contribute
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to almost 50% of T1D susceptibility and have become one of the criteria to diagnose T1D
along with presence of islet autoantibodies. However, there are also non-HLA genes that
confer T1D risk as recently pointed out by Genome Wide Association S tudies(GWAS).
GWAS analysis uncovered about 40 genetic loci that can predispose an individual to T1D
(International Diabetes Federation 2017). Most of the T1D risk associated genes confirm
the involvement of HLA complex, however there are also T1D susceptible genes expressed
in islets suggesting additional molecular mechanisms other than immune response
(Patterson et al. 2014).

At the site of target pancreatic tissue, histological studies of T1D pancreata have shown
more inflamed islets with higher levels of B and T lymphocytes infiltration in islets of
young

children compared T1D onset in adult age (M. A. Atkinson et al. 2015).

Additionally, Campbell-Thompson et al. recently have shown insulitis appearance based
on presence of CD3+ cell in islets has chronic and heterogeneous distribution among T1D
donors which depended on T1D duration rather than age of onset. Insulitis was observed
in both antibody positive donor as well as well as long standing T1D donors (CampbellThompson et al. 2016). On the other hand, chronic viral infection in implicating immune
response in T1D has been extensively discussed from evidences of viral protein and RNA
observed in islets along with type 1 interferon signatures(Filippi and Von Herrath 2008).
However, whether the viral signatures are cause or consequence of T1D is still unknown.
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Therapeutic interventions in restoring β cells
Apart from immune response, lack of functional β cells still remains a major hurdle in T1D
attracting immediate therapeutic focus towards understanding major determinants of β cell
proliferation. Current research efforts include exploring regenerative potential of β cells or
enhancing β cell proliferation through in situ approaches, shown in Figure 1.8. For example
stimulating regeneration from remaining β cells, potentiate maturation of immature β cells,
and

transdifferentiation

routes

from

non-β

cell

sources

or

from

putative

progenitors(neogenesis)(Tritschler et al. 2017; Aguayo-Mazzucato and Bonner-Weir
2017). Taking advantage of common lineage of β cells with other pancreatic cell types and
ectopic expression of key transcription factors important for β cell identity in acinar cells
have facilitated the conversion to β like cells. Evidence of duct cells differentiating into
insulin positive cells has been shown as well(Aguayo-Mazzucato and Bonner-Weir 2017).
Additionally, α and d cells converting to β cells has been reported in mice demonstrating
plasticity of the endocrine cells. However, making the β cell like to mimic true function,
glucose responsive and escaping immune attack is still a challenge. In this regard, inherent
β cell heterogeneity in terms of variation in glucose response, proliferation capacity and
maturation has been of great interest. Recently, many evidences support the notion that β
cell do not entirely contain homogeneous population of cells (Gutierrez, Gromada, and
Sussel 2017). Single cell gene expression studies in islets have begun to unravel cell-cell
variability on a transcript level in pancreatic islets that was poorly understood before.
However, limited number of single cells analyzed and possibly absence of gold standard
single cell data analysis methods has resulted in variable conclusions regarding existence
of β cell subpopulations. For more reproducible outcome in future, profiling larger number
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of single cells and analysis methods tested under multiple datasets can output consistent
results.

Figure 1.8: Possible approaches to restore β cell mass. Image adapted with
permission from Tritschler et al., 2017
Aims of Dissertation:
Low availability of human pancreatic tissue from type 1 diabetic donors (T1D) for research
has limited our efforts to study functional and molecular signatures of the pancreas and
islets in T1D state. Major aim of this dissertation is to understand properties of altered
characteristics and signature from remaining hormone positive cells in pancreatic islets
from individuals with T1D. Additionally, knowledge of intrinsic heterogeneity of β cells
and α cells of normal human pancreatic islets are incomplete. This dissertation also aims
to examine transcriptional profile of islets through single cell resolution to add new
understanding on the extent of possible transcriptional heterogeneity in two abundant cell
types of islets, α cells and β cells.
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Overcoming the limited pancreatic tissue availability, Chapter 3 highlight findings from
comprehensive study of remaining β cells and α cells from pancreatic islets of individuals
with T1D. This was possible through a unique infrastructure for tissue collection of T1D
pancreas and isolated islets of recent and longstanding T1D from collaboration of various
established organization (Figure 3.1).

Additionally, novel approach of procuring

pancreatic tissue and islets from same donor allowed molecular and functional analysis of
β cells and α cells within the context of their native organ. With such approach, we aimed
to find whether the remaining α cells and β cells in T1D islets were functionally normal in
terms of their ability to secrete their respective hormones and express key transcription
factors essential for proper identity and function.

Limited number of single cells from pancreatic islets has been profiled in the past that
might have failed to capture rare subpopulations of cells within islets cells. To advance our
knowledge in understanding intrinsic transcriptional heterogeneity of α and β cells in
pancreatic islets from normal individual, we applied a high throughput droplet based
approach to profile ~40,000 single cells of islets. By leveraging a large sample size, we
aimed to find existence of α and β subpopulations with distinct transcriptional feature from
healthy human pancreatic islets. Findings from this study would be crucial in exploring the
significance of heterogeneous role of β and α subpopulation in normal and diseased state
for future.

The experimental details of this study are summarized in Chapter 2 with details whereas
discussion of significance of the findings and future directions are details in chapter 5.
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Chapter 2
Materials and Methods
Methods for chapter 3 have been published in Marcela Brissova*, Rachana Haliyur*,
Diane Saunders*, Shristi Shrestha*, Cell Reports (2018). *co-first authors.

Methods for Chapter 3
Primary cell cultures
Primary human islets were cultured in CMRL 1066 media (5.5 mM glucose, 10% FBS,
1% Pen/Strep, 2 mM L-glutamine) in 5% CO2 at 37°C for 24-72 hours. No cell lines
were used in this study.

Human subjects and Pancreatic Islet Procurement

Human pancreata (normal and T1D donors) were collected by our collaborators, Dr.
Powers group, Vanderbilt University, who are in partnership with the International Institute
for Advancement of Medicine (IIAM), National Disease Research Interchange (NDRI),
Integrated Islet Distribution Program (IIDP), and Network for Pancreatic Organ Donors
with Diabetes (nPOD) for an organized procurement of human pancreas (Figure 3.1). Most
pancreata from normal donors were processed either for islet isolation or histological
analysis. In most T1D pancreatic organs, islets and tissue specimens were procured from
the same organ. For a number of controls, human islets were obtained through IIDP. Donor
demographic information and phenotype of T1D donors is summarized in Table 3.1. The
Vanderbilt University Institutional Review Board declared studies on de-identified human
pancreatic specimens does not qualify as human subject research.
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Pancreata from normal juvenile and T1D donors were received within 18 hours from cold
clamp and maintained in cold preservation solution on ice until processing. Pancreas was
then cleaned from connective tissue and fat, measured and weighed. Pancreatic organs
were processed for islet isolation using an approach previously described (Balamurugan et
al. 2003). Briefly, depending on the size of pancreatic duct, 18G or 22G catheters were
inserted into the main pancreatic duct (one catheter towards head and the other one towards
tail). Accessory duct and main pancreatic duct were clamped at the points where sections
were collected to prevent leakage of collagenase solution during infusion. Collagenase
solution (Serva NB1, neutral protease, Serva, Germany) pre-warmed to 28ºC was delivered
intraductally using a Rajotte’s perfusion system and then maintained at 37ºC for
approximately 20min. The inflated tissue was then transferred to a Ricordi’s chamber
apparatus for combined mechanical and enzymatic digestion, which was maintained at
36ºC for 5-15 minutes prior to warm and cold collection. Following a cold incubation of
the digest in University of Wisconsin solution for 1 hour on ice, a purification step
consisting of discontinuous density gradient centrifugation on a COBE 2991 Cell Processor
(Gambro-Terumo, Lakewood, CO) was carried out. On average, islet-enriched fraction
contained from 30,000 (T1D pancreas) to 90,000 islet equivalents (IEQs) (normal
pancreas) with 25 – 50% purity. Islets were cultured for 12 – 24 hours and then shipped
from Pittsburgh to Vanderbilt University and/or University of Massachusetts for further
analysis following shipping protocols developed by the Integrated Islet Distribution
Program (IIDP, iidp.coh.org). Subsequent assays with isolated islets were set up
immediately upon islet arrival.
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Assessment of pancreatic islet function in vitro
Function of islets from T1D donors and normal controls was studied in a dynamic cell
perifusion system at a perifusate flow rate of 1 mL/min (Kayton et al., 2015). The effluent
was collected at 3-minute intervals using an automatic fraction collector. Insulin and
glucagon concentrations in each perifusion fraction and islet extracts were measured by
radioimmunoassay (insulin, RI-13K, Millipore; glucagon, GL-32K, Millipore).

qRT-PCR of isolated pancreatic islets
Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was performed
using the primer-probe approach from Applied Biosystems (Life Technologies, Grand
Island, NY) with 18S and ACTB endogenous controls using Minimum Information for
Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines as described
(Brissova et al., 2014).

α cell sorting by flow cytometry for RNA-sequencing
Human islets were dispersed using a modified protocol as described previously(Dorrell et
al. 2016). Briefly, 0.025% trypsin was used to disperse cells and reaction was quenched
with modified RPMI medium (10% FBS, 1% Penn/Strep, 5 mM glucose). Cells were
washed in the same medium and counted on a hemocytometer, then transferred to FACS
buffer (2 mM EDTA, 2% FBS, 1X PBS). Indirect antibody labeling was completed via
two sequential incubation periods at 4C, with one wash in FACS buffer following each
incubation. Primary and secondary antibodies have been characterized previously and used
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to isolate high-quality RNA from α cells (Trapnell, Pachter, and Salzberg 2009b) .
Appropriate single-color compensation controls were run alongside samples. Prior to
sorting, propidium iodide (0.05ug/100,000 cells; BD Biosciences, San Jose, CA) was
added to samples for non-viable cell exclusion. Flow analysis was performed using an
LSRFortessa cell analyzer (BD Biosciences, San Jose, CA), and a FACSAria III cell sorter
(BD Biosciences, San Jose, CA) was used for FACS. Analysis of flow cytometry data was
completed using FlowJo 10.1.5 (Tree Star, Ashland, OR).

Immunohistochemical Analysis
Immunohistochemical analysis of pancreas was performed on serial 5-µm cryosections
from multiple blocks from head, body and tail regions as described (Brissova et al., 2014).
Digital images were acquired with a Zeiss LSM510 META laser scanning confocal
microscope (Carl Zeiss; Jena, Germany) or a ScanScope CS (Aperio, Vista, CA).

RNA isolation, NGS library preparation and Sequencing
RNA was isolated from whole islets and sorted α cells (5,000-125,000) using RNAqueous
micro-scale phenol-free total RNA isolation kit (Ambion, Austin, TX). Trace DNA was
removed with TURBO DNA-free (Ambion, Austin, TX). The concentration and integrity
of the extracted total RNA was estimated by Qubit® 2.0 Fluorometer (Invitrogen,
Carlsbad, California, USA), and Agilent 2100 Bioanalyzer (Applied Biosystems, Carlsbad,
CA, USA), respectively. RNA samples with a RIN value of at least 7.0 or higher was used
for further processing. Total RNA from each sample was amplified using the Ovation®
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RNA-Seq system V2 amplification kit (NuGen Technologies, San Carlos, CA) using
manufacturer's instruction. The amplified product was purified using MinElute PCR
Purification and final elution was made in 30µl Elution (EB) buffer (Qiagen Inc., Valencia,
California, USA). Final yield and quality was checked again using Qubit® 2.0 Fluorometer
and DNA 1000 chip on the Agilent 2100 Bioanalyzer, respectively. Approximately, 2 µg
amplified DNA from each sample was sheared on a Covaris S200 focused-ultrasonicator
(Woburn, MA, USA) with a target yield of 200bp fragment size.
Post sheared material was analyzed on a DNA 1000 chip on Agilent 2100 Bioanalyzer to
confirm the targeted fragmentation size. Following this the fragmented DNA was taken
into standard library preparation using NEBNext® DNA Library Prep Master Mix Set for
Illumina® (New England BioLabs Inc., Ipswich, MA, USA) with slight modifications.
Briefly, after sonication "End-repair" followed by "polyA addition" and "adapter ligation"
was done. Post-ligated material was individually barcoded with unique in-house
GSL(Genomic Services Lab, HudsonAlpha Institute for Biotechnology, Huntsville, AL)
primers and PCR amplified through 6 cycles. The quality of the libraries was assessed
by Qubit® 2.0 Fluorometer, and the concentration of the libraries was estimated by
utilizing a DNA 1000 chip on an Agilent 2100 Bioanalyzer, respectively. Accurate
quantification for sequencing applications was determined using the qPCR-based KAPA
Biosystems Library Quantification kit (Kapa Biosystems, Inc., Woburn, MA, USA). Each
library was then diluted to a final concentration of 12.5nM and pooled equimolar before
clustering. 50bp Paired End sequencing was performed to generate approximately 50
million reads per sample on Illumina HiSeq 2500 (Illumina Inc., San Diego, CA, USA).
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Base calling and quality metrics of the reads were reviewed generated by real-time analysis
(RTA) through Sequence Analysis Viewer v2.1.8.

QUANTIFICATION AND STATISTICAL ANALYSIS
Quantification of cellular protein expression
Histopathology reviews were conducted on the whole slide digital images. Protein
expression of nuclear factors in α and β cells was quantified using MetaMorph 7.1 imaging
software (Molecular Devices, Downingtown, PA) using manual cell counting (Brissova et
al., 2014) where an average of 351±73 α cells and 861±141 β cells were counted per normal
donor (n=7), and average of 718±50 α cells and 45±17 β cells were counted per T1D donor
(n=4) for each transcription factor.

RNA-Seq Data Analysis
Further downstream analysis of the sequenced reads from each sample was performed as
per our unique in-house GSL pipeline. Raw reads were demultiplexed using bcl2fastq
software v1.8.3 2500 (Illumina Inc., San Diego, CA, USA) and quality of reads were also
assessed by FastQC (Babraham Bioinformatics, London, UK). Next, reads were mapped
to the reference human genome hg19 using TopHat v2.1(Trapnell et al. 2009). The
alignment metrics of the mapped reads was estimated using SAMtools ( Li et al. 2009)
. Aligned reads were then imported onto the commercial data analysis platform, Avadis
NGS (Strand Life Sciences, Bengalor). The aligned reads were filtered on the basis of read
quality metrics where reads with a base quality score less than 15, alignment score less
than 90, reads with length less than 20, reads with more than 2 mismatches and mapping
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quality less than 40 were removed. Reads that passed the filters were then further filtered
on the basis of their read statistics, where missing mates, translocated, unaligned, flipped
reads and duplicates were removed. Transcripts were quantified from the resultant reads
using the TMM (Trimmed Mean of M-values) algorithm (Dillies et al. 2013; Robinson and
Oshlack 2010) as the normalization method. Genes with normalized expression values less
than 25 were removed prior to differential expression analysis between patients grouped as
control and T1D groups. Fold change (cutoff ≥ ±1.5) between control and T1D group was
calculated for differential expression and the p-value of differentially expressed gene list
was estimated by z-score calculations (cutoff 0.05) along with Benjamini Hochberg false
discovery rate (FDR) correction of 0.05(Benjamini and Hochberg 1995). Ingenuity
Pathway Analysis (IPA, QIAGEN, Redwood City, CA) was used for functional pathway
analysis and Database for Annotation, Visualization and Integrated Discovery (DAVID
v6.8, http://david.abcc.ncifcrf.gov) (Huang et al. 2009)was used for gene ontology (GO)
enrichment analysis respectively. The significance of canonical pathways from IPA and
their association to up and downregulated gene list in our data was determined by
Benjamini-Hochberg corrected Fisher tests. Canonical pathways identified to be activated
or inhibited is a prediction from IPA based on z-score algorithm that compares up and
down gene list with canonical patterns from IPA Knowledge database. The canonical
pattern recognizes key molecules in the pathway that can activate it or inhibit based on
IPA’s manually curated literature findings to generate a pattern for molecules. Our study
only listed canonical pathways that had p<0.05 and Z-Score>2 or <-2. Further
visualizations of 2D PCA plots were generated on Avadis NGS software whereas
Spearman correlation and Volcano plots were generated using R version 3.2.4
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Methods for Chapter 4
Human pancreatic islets and generating single cell libraries
Human pancreata from cadaveric donors were collected through Integrated Islet
Distribution Program (IIDP)(https://iidp.coh.org/) in collaboration with Dr. Powers
research group, Vanderbilt University. Donor clinical and demographic information is
summarized in Table 4.1. Islets were trypsin dissociated and washed in 0.04%BSA+1xPBS
twice. Cell count and viability check was done using trypan blue based measure from
Countess™ II Automated Cell Counter (https://www.thermofisher.com/order/catalog/
product/AMQAX100). Next, recommended cell suspensions from 10x user guide for
single

cell

3’

Kit

v2

(https://support.10xgenomics.com/single-cell-gene-

expression/library-prep)were loaded targeting cell recovery of 10,000 cells per channel.
10x Genomics ChromiumTM controller (Pleasanton, CA, USA) was used to isolate single
cell in GEMs (Gel Bead in Emulsions) and Single Cell 3’ Reagent Kits v2 protocol for
subsequent single cell library generation. Within each GEMs, single cell and gel beads
functionalized with 10x barcodes and Unique Molecular Identifier (UMI) carrying oligos
is encapsulated. Single cells are lysed and reverse transcription is carried out inside the
GEMs such that each cDNA is tagged with same 10x barcode and every transcript is tagged
with Unique Molecular Identifier (UMI). cDNA is PCR amplified followed by enzymatic
fragmentation and SPRI double sided size selection for optimal cDNA size. Next, end
repair, A-tailing, Adaptor Ligation, and PCR were done for final libraries generation that
have P5 and P7 primers compatible with Illumina sequencing. Single cell libraries were
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pooled and sequenced in Hiseq platform with 100 cycles paired end (26 bp Read 1, 8 bp I5
Index, and 98 bp Read 2).

Single Cell RNA Sequencing data analysis
Initial barcode processing, alignment and transcript count was done using 10x Genomics’s
software

suite,

Cell

Ranger

(https://support.10xgenomics.com/single-cell-gene-

expression/software/pipelines/latest/what-is-cell-ranger). Cell ranger mkfastq carried out
the barcode aware demultiplexing from bcl to fastq files. Next, cell ranger count was used
to generate single cell gene counts for single library. Refdata-cellranger-GRCh38-1.2.0
was used for transcriptome reference. All libraries from all three donors were combined
and normalized for sequencing depth by subsampling from high depth libraries until equal
number of confidently mapped reads per cell was obtained using cell ranger aggr. Cell
ranger output gene-barcode matrix was further processed in Seurat package v2.0 pipeline
(http://satijalab.org/seurat/ ), an R toolkit for single cell data analysis. For initial filtering,
low quality cells were defined by cells with genes detected less than 200, cells expressing
mitochondrial genes >15% (marker of apoptosis). Also, genes not expressed in ³ 3 cells
were removed. Any cells expressing greater than 4500 genes were removed to exclude
possible cell doublets. With an attempt to control for contamination stemming from nonintact cells, cells that express TM4SF4 (known α cell marker) and ENTPD3 (known β cell
marker) was used to analyze α and β cell subpopulation. Remaining 26,048 cells were
further analyzed for cell type annotation. Gene expression measurements for each cell are
normalised by its total expression, scaled by 10,000, and log-transformed. Common source
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of variation in clustering like number of transcripts per cell and percentage mitochondrial
RNA was removed using Seurat ScaleData() function. Next, genes that are similarly
expressed in cells have low cell type distinguishing power so only highly variable genes
are selected using Seurat’s FindVariableGenes() function and further used as input for
principal component analysis (PCA) using Seurat’s RunPCA() function. The number of
PCs to include in downstream clustering is chosen based on standard deviations of
Principal Components by using PCElbowplot() function of Seurat to determine statistically
significant PCs. First 10 significant principal components were further used for
downstream graph based clustering approach from Seurat. In this approach, cells are
embedded in graphical structures (K-nearest neighbor graph) based on Euclidean distance
in PCA space. Smart local moving algorithm for modularity is used for clustering. Seurat’s
FindClusters() was used for clustering with parameters (reduction.type = "pca",dims.use =
1:10,resolution = 0.4,print.output = 0,save.SNN = TRUE). Various resolution parameter
(0.4, 0.6, 1) was tried to adjust granularity of the clustering. On instance of cells
overclustering, we merge clusters expressing similar gene marker of a cell type (clusters
expressing INS were merged to define β cells, GCG expressing clusters were merged to
define α cells and so on). t-distributed stochastic neighborembedding (t-SNE) was further
used for visualization using function RunTSNE() with parameters(dims.use = 1:10, do.fast
= TRUE). Markers for each clusters were determined by differential expression analysis
through FindAllMarkers() function using parameters (test.use = "bimod", do.print =
TRUE,min.pct = 0.25). It compares genes in one cluster against all other clusters and then
repeats for each clusters. As a prefiltering step, parameter min.pct=0.25 was applied that
requires genes to be detected at least in 25% of the two group of cells and likelihood ratio
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test(McDavid et al. 2013) was used for differential expression. Other differential
expression supported by Seurat was also tried (ROC, t-test) and correlation of results from
different test were similar (data not shown). All visualization plot shown in chapter 4 were
produced using Seurat (PCA, violin plots, tSNE, heatmaps, dotplots, feature plots).
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Chapter 3
Remnant β Cells in Recent-onset Type 1 Diabetes Have Essentially Normal Gene
Expression and Function, but α Cells Are Significantly Compromised

Most text and data in this chapter have been published in Marcela Brissova*, Rachana
Haliyur*, Diane Saunders*, Shristi Shrestha*, Cell Reports (2018). *co-first authors.

Introduction
T1D is characterized by autoimmune associated loss of β cells. T cells mediates the β cell
death by recognizing various autoantigens in pancreatic islets (Todd 2010). Our
understanding of events leading to immune response towards β cells and metabolic events
that triggers the β cell loss is still limited. Non-obese diabetic rodent model has been
studied to a great extent investigating islets and β cell phenotypes in T1D, however
knowledge of alterations occurring in human T1D islets is limited due to scarcity of human
tissue for research. Overcoming the limited availability of human pancreatic tissue through
cadaveric donors, only recently have we recognized the differences in islets of rodents and
humans. Rodent islets are dissimilar compared to human in islet architecture,
vascularization, cell composition and basal insulin level (Dai et al. 2012). These differences
highlight the importance of studying human islets and revisit studying the T1D phenotypes.

Recent studies show that T1D patients do not undergo complete loss of β cells during
disease process and that they can contain insulin secreting β cells even 50 years post
diagnosis (Keenan et al. 2010; Oram et al. 2014). Little is known about the nature of these
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remaining β cells and their functional state. On the other hand, α cells, another abundant
cell type in islets, produce glucagon that has a critical role in preventing hypoglycemia
during fasting state and counter-regulating the insulin action of β cells. In T1D, not long
after disease onset, counterregulatory glucagon response to hypoglycemia is lost (Kramer
et al. 2014). Moreover, T1D patients shows impaired glucagon suppression postprandial
which commonly results in hyperglucagonemia (Kramer et al. 2014). However, the cause
of abnormal glucagon response and the extent of functional defect in T1D α cells is not
well known. Additionally, α cell’s ability to transdifferentiate into β cells under extreme β
cell loss has been discussed recently. For example, β cell mass ablation in mice ensues
trans-differentiation from α cells and d cells into insulin producing β cells(Chera et al.,
2014; Thorel et al., 2010). Also, trans-differentiation of α to β has been attempted by
reprogramming α cells to express transcription factor PAX4, PDX1, NKX6.1(Collombat
et al. 2009; Schaffer et al. 2013b; W. Wang et al. 2011). However, we do not know whether
such α cell plasticity exists in T1D islets, given extreme β cell loss condition of T1D.

With a novel approach of studying pancreas and isolated islets from same organ donor, we
collectively defined hormone secretory functional state and molecular features altered in
T1D islets in context of native organ. For functional study, we assessed insulin secretion
and glucagon secretion in islets of T1D as well as normal donors and found that remaining
β cells in T1D confer normal insulin secretion compared to control subjects but α cell’s
ability to secrete glucagon were impaired. We further studied gene expression profiles of
whole islets and purified α cells from T1D donors using RNA-sequencing. Our RNAsequencing results in purified α cell population have shown that several key transcription
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factors that specifies α cell fate and function were being compromised and additionally,
express a β cell specific transcription factor, NKX6.1, also supported by histological
assessment on pancreatic tissue. Interestingly, gene expression related to immune and
stress response was also detected in T1D α cells. Based on these evidences, we propose a
model for disruption of α function. We further assessed alterations in transcript level of
T1D whole islets and found that differentially expression of transcripts in T1D whole islets
were associated to innate immune response, viral response and apoptosis. These results
further our understanding into functional and molecular profile of islets in T1D.

Results

Procurement of Pancreatic Islets and Tissue from the Same Organ Donor Allows for
Multifaceted Phenotypic Analysis of T1D Islets
Samples were obtained through an organized collaborative infrastructure that included
organ procurement organization, islets isolation centers and expertise at Vanderbilt
University indicated in Figure 3.1. Such infrastructure allowed islet functional and
molecular analysis with histological assessment of islets in context of the native organ.
Figure legends in Table 3.1 shows the donors used for each experimental analysis and we
defined recent-onset T1D as duration <10 years while long-standing T1D as duration >10
years. In order to define T1D phenotype, we studied T1D islets by measuring insulin and
glucagon secretion in vitro through dynamic perifusion assay and transcriptome of T1D
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whole islets and sorted α cell population from RNA-sequencing. Also, we further analyzed
pancreatic tissue histologically for islet morphology and TF expression whereas
information on serum autoantibodies and C-peptide were collected along with redacted
patient information on donors receiving continuous insulin therapy and HLA typing (Table
3.1.)(Figure 3.2A)
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Table 3.1: Demographic information and Phenotype of T1D Donors
Donors

1

2

Age

12

13

T1D
Duration
(Years
)

Ethnicity

Gender

BMI

3

Caucasian

F

26.6

5

Caucasian

M

19.1

Cause
of
death

Highrisk
HLA

Auto
Ab

DR3,
DQ2

mIA

Anoxia

DR4
DQ2,
DQ8

IA2A

Anoxia

CPeptide
(ng/m
L)

Hb
A1
C

0.05

9.8

A

mIA

N/
<0.02
A

A
IA2A

3

14

2

Caucasian

F

24.3

Anoxia

DR4

mIA

0.26

9.2

A

4

5

20

22

7

6

Caucasian

Caucasian

M

F

25.5

24.7

Anoxia

Anoxia

N/

DR4
DQ2,
DQ8

IA2A

DR3

GAD

DR4,

A

DQ2

IA2A

0.43
A

<0.02

DR4
6

27

17

Caucasian

M

18.5

Anoxia

DQ2,

N/
ND

<0.02

ND

<0.02

N/A

N/A

A

DQ8
DR4,
7

30

20

Caucasian

M

29.8

Anoxia

8

58

31

Caucasian

M

21.7

Anoxia

DQ8
DR4

6.6

N/
A
8.8

BMI – Body mass index, AutoAb – Autoantibodies, mIAA – Insulin autoantibody,
IA2A – Autoantibody to transmembrane protein of the protein tyrosine phosphatase
family, GADA – Glutamic acid decarboxylase autoantibody, HbA1c – Hemoglobin
A1c, N/A – Not available, ND – Non- detectable. Perifusion – Donors 1, 4, and 5, Islet
endocrine cell composition by FACS – Donors 1, 4, 5, and 8, Histology – Donors 1, 2, 5,
and 8, α cell purified RNA-sequencing – Donors 3, 6, and 7 and Whole islets RNAsequencing – Donors 3 and 4
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Table 3.2: Demographic information of Normal Donors
Donors

Normal
Control
for Islet
Perifusion

Normal
Control
for qRTPCR

Normal
Controls
for
Histology

Normal
Controls
for RNASeq of α
cells

Normal
for RNASeq of
Whole
islets

Age
(years)

Ethnicity/Race

Gender

BMI

Cause
Of
Death

7

Caucasian

M

26.8

Respiratory arrest

8

Caucasian

F

16.1

Intracerebral
hemorrhage

8

African American

M

17.2

Anoxia

9

Caucasian

M

15.5

Head Trauma

11

African American

M

18.3

Anoxia

19

Caucasian

M

20.1

Head Trauma

21

Caucasian

M

21.7

Head Trauma

11

Caucasian

M

22.7

Anoxia

20

Hispanic/Latino

F

24.6

Anoxia

29

Hispanic/Latino

M

27.5

Head Trauma

8

African American

M

17.2

Anoxia

10

Caucasian

M

19.3

Head Trauma

19

Caucasian

M

20.1

Head Trauma

19

Caucasian

M

21.2

Anoxia

20

Hispanic/Latino

M

19.4

Head Trauma

24

Caucasian

M

35.5

Head Trauma

55

African American

M

35.6

Stroke

26

Hispanic/Latino

F

35.9

Anoxia

35

Caucasian

F

23.6

Anoxia

49

Caucasian

F

31.6

Stroke

50

African American

M

30.2

Stroke

55

Caucasian

M

27.8

Stroke

24

Caucasian

M

35

Head trauma

26

Hispanic/Latino

F

35.9

Anoxia

55

Caucasian

M

27.8

Stroke

16

Caucasian

M

23

Overdose

35

Caucasian

F

23.6

Anoxia

50

African American

M

30.2

Stroke
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Figure 3.1: Infrastructure for T1D human pancreas and islets procurement. IIAMInternational Institute for the Advancement of Medicine, NDRI-National Disease Research
Interchange, HIRN-Human Islet Research Network, NIH-National Institute of Health,
JDRF-Juvenile Diabetes Research Foundation, nPOD-Network for Pancreatic Organ
Donors with Diabetes. Schematic is courtesy of Marcela Brissova, Vanderbilt University.

A.
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B.

Figure 3.2: (A) Schematic of approaches to define T1D islet phenotype. (B)
Immunolabeling for T1D islets for INS-insulin, GCG-glucagon, SOM-somatostatin.
On average 250 islets from T1D donor were analyzed for the presence of β cells. Islet was
categorized as insulin+ even if it had only one insulin positive cell. The number of insulin+
islets varied in 3 donors with recent-onset T1D (17.8±15.5%), but no insulin+ islets were
found in the pancreatic sections of our longstanding cases. If donors had insulin+ islets,
representative islets are displayed in row 1. Scale bar is 50 µm.

T1D β Cells Have Regulated Insulin Secretion and Express Key Transcriptional
Regulators
Through dynamic perifusion system, we assessed insulin secretion capacity of T1D islets
subjected to basal glucose, high glucose and various secretagogues. Remaining β cell in
T1D islets in response to glucose, cyclic AMP (cAMP)-evoked stimulation, and KClmediated depolarization had similar profile as normal islets (Figure 3.3A and 3.3B). The
attenuated initial first phase of glucose stimulated insulin is known to be a hallmark of β
cell dysfunction and has been reported before in T1D islets(Krogvold et al. 2015). When
insulin secretion was normalized to islet cell volume, insulin level is decreased (Figure
3.3A) where reduced level reflects lower β cell mass. However, when the insulin secretion
is normalized to islet insulin content that reflects secretion from specifically β cells, the
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insulin level was comparable to that of normal in terms of magnitude (Figure 3.3B). T1D
β cell population was 4-6 fold less than in control islets when adjusted to islet insulin
content (Figure 3.3C). We further analyzed key transcription factor PDX1(Gao et al. 2014)
and NKX6.1(Schaffer et al. 2013b) that are essential for β cell identity and function.
Analysis from qRT-PCR showed that these transcription factors were not altered in T1D
compared to control (Figure 3.3D) which was supported by unchanged expression at
protein level in native pancreatic tissue (Figure 3.3 E, F). Further considering expression
of transcription factor MAFA(Guo et al. 2013) typically required in murine mature β cells,
were reduced in T1D islets (Figure 3.3D) but NKX2.2 was reduced only in protein level
but not mRNA level (Figure 3.3D, 3.3G). These evidences suggest T1D β cells have near
normal functional features which suggest T1D progress possibly from β cell loss rather
than loss of function. Unfortunately, reduced β cell fractions in T1D (Figure 3.2 B) prevents
efforts to purify β fraction for gene expression study. Therefore, we further purified and
characterized abundant cell type in T1D islets, α cells.
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Figure 3.3. Recent-onset T1D islets have near normal insulin secretion and their gene
expression pattern is similar to normal β cells. (A, B) Insulin secretion was assessed in
islets isolated from donors with recent-onset T1D (n=4; ages 12-22yrs) and compared to
normal controls (n=7; ages 7-21yrs); G 5.6 – 5.6 mM glucose, G 16.7 – 16.7 mM glucose,
G 16.7 + IBMX 100 – 16.7 mM glucose + 100 µM isobutylmethylxanthine (IBMX), G1.7
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+ Epi 1 – 1.7 mM glucose + 1 µM epinephrine, KCl 20 – 20 mM potassium chloride. (A)
Insulin secretion normalized to overall islet cell volume (expressed as islet equivalents,
IEQs); p<0.0001. (B) Insulin secretion normalized to islet insulin content; p=0.2754. (C)
Insulin content in control (3.873±0.763 ng/IEQ) and T1D islets (1.131±0.660 ng/IEQ);
p=0.0394. (D) Expression of β cell-enriched transcription factors by qRT-PCR in whole
T1D islets (n=3; ages 12-22yrs) and controls (n=3; ages 11-29yrs) was normalized to
endogenous control and INS expression; ***, p<0.0007. (E – G) Expression of β cellenriched transcription factors in the native pancreatic tissue from donors with recent-onset
T1D (n=4; ages 12-22yrs) was compared to 58-year-old donor with 31 years of T1D
duration and controls (n=7; ages 8-55yrs). The pancreas of 58-year-old T1D donor did not
have any insulin+ islets; only rare β cells were found in exocrine parenchyma. T1D β cells
(n=4; ages 12-58yrs) had normal expression of β cell-enriched transcription factors PDX1
(E) and NKX6.1 (F) but decreased expression of NKX2.2 (G); ****, p<0.0001. Scale bar
in E represents 10 µm and also corresponds to F and G.

T1D α cells Have Altered Expression of Transcription Factor Constituting α and β
Cell Identity and Additionally Indicate Immune Pathway Activation and Increased
Stress Response

Perifusion analysis showed that despite of high α cell number in T1D islets, glucagon
secretion in T1D islets were not significantly increased when normalized to islet cell
volume compared to normal (expressed as IEQs; Figure 3.4A). Interestingly, T1D islets
had decreased glucagon response when normalized to glucagon content (Figure 3.4 B and
C). Contrary to normal donors, T1D islets had lowered glucagon response at low glucose
following 30 min high glucose inhibition (Figure 3.4B).Such altered glucagon secretion
has been reported previously in islets isolated from a single T1D donor 8 months after the
disease onset (Marchetti et al. 2000). In line with the functional α cell defect, were reduced
expression of ARX and MAFB shown by qPCR (Figure 3.4D). ARX and MAFB are bona
fide transcription factors that regulates α cell function (Courtney et al. 2013; Guo et al.
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2013). This result was further supported by histological analysis that showed reduced
expression of ARX and MAFB. Surprisingly, a β cell transcription factor NKX6.1 was
expressed in low levels (Figure 3.4 E, F, G). This expression of β cell marker in α cells
could possibly suggest ongoing trans-differentiation from α to β. Transdifferentiating
events of α-β conversion have been demonstrated previously under extreme β cell loss
conditions and under inactivation of ARX and the DNA methyltransferase Dnmt1 in mice
(Chakravarthy et al. 2017; Chera et al. 2014; Thorel et al. 2010). However, we did not find
any bihormonal cells (expressing both insulin and glucagon) to further support the α to β
conversion.

We further purified α cells present in T1D islets by fluorescence-activated cell
sorting(FACS) using pan endocrine specific (HPi1+) and α cell specific (Hpa3) surface
antibodies (Figure 3.4 H). These marker antibodies used for sorting have been
characterized previously and used to obtain enriched α cells with high quality RNA(Dorrell
et al. 2016). To assess α cell dysfunction in mRNA level, we compared the transcript profile
of sorted α cells of control and T1D samples (Table 3.1 and 3.2). For RNA-Sequencing,
we prepared mRNA libraries and sequenced all samples from control and T1D using
Illumina HiSeq 2500 platform generating close to 50 million reads per sample. Initially,
principal component analysis (PCA) was conducted to assess the pairwise relationship
between all samples from control and T1D and found that control α cell samples clustered
separately from those of T1D α cells (Figure 3.5). PCA was followed by unsupervised
hierarchical clustering, which verified the separation of clusters of control and T1D
samples suggesting significant difference of gene expression pattern (Figure 3.6). After
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transcript normalization and quantification (Methods, Chapter 2), differential expression
was defined as genes greater than 1.5-fold increased expression in T1D compared to
control with p-value cutoff < 0.05. Out of 3671 genes differentially expressed in T1D
compared to control α cells, 1673 genes were upregulated while 1998 genes were down
regulated (Figure 3.7).

We investigated previously known key genes important for α cells identity and function.
mRNA expression levels of transcription factors ARX and MAFB were decreased more
than 2-fold and 3-fold respectively and β cell specific transcription factor NKX6.1 was
increased 1.5-fold which is in line with RT-PCR analysis (Figure 3.4D, 3.8). This result
correlates with protein level analysis by histological assessment of the pancreatic tissue
where ARX and MAFB had reduced expression and expressed low levels of
NKX6.1(Figure 3.4 E, F, G). Among the islet enriched transcription factors, RFX6 was
most reduced with 7.2-fold downregulation. RFKX6 is a transcription factor known to lie
upstream of MAFB, ARX and NKX6-1 and downstream from NEUROD 3 (endocrine
progenitor) in the hierarchy of transcription factor that governs endocrine cell
differentiation (Piccand et al. 2014; Smith et al. 2010). RFX6, in mature mouse and human
β cells is known to regulates the insulin secretion by directly controlling expression of P/Q
and L type voltage gated calcium channels (CACNA1A, CACNA1C, and CACNA1D) and
the KATP channel subunit sulfonylurea receptor 1 (ABCC8) (Chandra et al. 2014; Piccand,
Strasser, Rutter, et al. 2014)that associates with Kir6.x pore-forming subunits(Winkler et
al. 2009). Additionally, T1D α cells also had altered expression of potassium and sodium
ion channels, vesicle trafficking proteins, and cAMP signaling molecules, which
collectively point to altered T1D a cell electrical activity and impaired glucagon exocytosis.
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For more comprehensive assessment of the biological processes implicated in T1D α cells,
gene ontology (GO) analysis of differentially expressed genes in T1D α was analyzed. GO
annotations mostly pointed to protein synthesis, immune activated signaling and cell to cell
communication (Figure 3.9). In addition, Ingenuity Pathway Analysis(IPA) was used to
further explore canonical pathways affected in T1D α cells (Figure 3.10). We narrowed the
canonical pathways list by z-score cutoff of ± 2 and p-value less than 0.05 resulting in 23
significant canonical pathways that mostly associated to cellular stress response and
immune signaling pathways (Figure 3.10). Among the cellular stress response pathways,
NRF2-mediated oxidative stress response and p38 MAPK signaling were activated (Figure
3.11A). Nuclear factor-erythroid 2 related factor2(NRF2) activation is associated to
cellular defense response due to oxidative stress by producing antioxidant and detoxifying
proteins. Genes associated to such antioxidants that functions downstream of NRF2 were
upregulated (ATF4, MRP1, MRP2, MRP4, TRXR1) (Figure 3.11A). Similarly, several
components of p38 mitogen activated protein family of kinases (p38 MAPK) pathway was
upregulated

(CREB5,

CREBBP,

MAP2K3,

MAP2K4,

MAP3K5,

MAPK14,

MAPKAPK2, MKNK2, SRF, ASK1.) which is typically prompted by various stress
stimuli that enhances increased transcriptional activity, protein synthesis and even
apoptosis (Figure 3.11A).
Furthermore, activation of pathways like macrophage migration inhibitory factor(MIF)
regulation, production of nitric oxide (NO) and reactive oxygen specied (ROS) in
macrophages indicates activation of innate immune response (Figure 3.10). MIF is an
important cytokine produced by macrophages and monocytes that exerts pro-inflammatory
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activity by inducing NF-kB members. NF-kB components along with IFNg receptor
(IFNGR1), TNF receptor (TNFRSF1A), JAK1 and MAPK members were upregulated in
T1D α cells possibly suggests an ongoing immune signaling and cell survival responses
(Figure 3.11 B). Upstream analysis from IPA predicts cascade of upstream transcription
regulators that explains the gene expression changes downstream. Some of the upstream
regulators predicted to be activated included NF-kB complex, T cell receptor complex and
various cytokines shown in Table 3.3, which further supports immune activity in T1D α
cells (Table 3.3). Additionally, pathways of B cell activating factor and B cell receptor
signaling was activated possibly suggesting T1D α cells also engaged in humoral immune
response (Figure 3.11 B).
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H.

HIC0-4F9

α-cells

HIC-3-2D12

Figure 3.4. Glucagon secretion is reduced in T1D islets and α cells have dysregulated
gene expression. The same sets of islets shown in Figures 1A and B were simultaneously
analyzed for glucagon secretion. The same non-diabetic controls were used as Figure 1.
The labeling of islet stimuli is identical to that in Figure 1. (A) Glucagon secretion
normalized to overall islet cell volume (expressed as islet equivalents, IEQs); p=0.2470.
(B) Glucagon secretion normalized to islet glucagon content; p<0.0001. Inset shows mean
glucagon response to low glucose following the 30-minute inhibition with high glucose.
(C) Glucagon content in control (206±62 pg/IEQ) and T1D islets (362±149 pg/IEQ);
p=0.2831. (D) Expression of α cell-enriched transcription factors by qRT-PCR in whole
T1D islets (n=3; ages 12-22yrs) and controls (n=3; ages 11-29yrs) was normalized to
endogenous control and GCG expression; ****, p<0.0001, *, p=0.0184. (E – G) Analysis
of native pancreatic tissue for expression of islet-enriched transcription factors. T1D α cells
(n=4; ages 12-58yrs) expressed β cell marker NKX6.1 (G) and lost bona fide α cell markers
MAFB (E) and ARX (F) in most T1D α cells compared to controls (n=7; ages 8-55yrs);
****, p<0.0001. Scale bar in E represents 10 µm and also corresponds to F and G. (H) The
α cell population was isolated based on double positivity for HIC3-2D12 (Hpa3) and HIC04F9 (Hpi1) antibodies.
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Figure 3.5: Principal component analysis (PCA) plot shows clustering of α cell
samples from control (n=5; ages 26-55yrs) and T1D (n=3; ages 14-30yrs) donors.

Figure 3.6: Heat map of the pairwise correlation between all samples based on the
Spearman correlation coefficient, which ranks and quantifies the degree of similarity
between each sample pair. Perfect correlation is indicated by 1
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Figure 3.7: Volcano plot of differentially expressed genes between control and T1D α
cells that reached statistical significance (upregulation: red; downregulation: green).
Differential expression of genes was based on fold change cutoff ³1.5 and p-value <0.05.

Figure 3.8: Genes associated with α cell identity and function are significantly
downregulated in the T1D α cells with increased expression of stress response factors
and cell junction proteins. Vertical dotted lines represent point of significance for
FC=1.5x threshold analysis; p<0.05
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Figure 3.9: GO term annotations from differentially expressed genes in T1D α cells
mostly pointed to protein synthesis, immune activated signaling and cell to cell
communication. Bar graph highlights the percentage of up- and down-regulated genes
(with corresponding gene number displayed within bar) in the top 20 significant biological
processes, cellular components, and molecular functions identified by Gene Ontology
(GO) term analysis. Differential expression of genes used for GO analysis was based on
fold change cutoff ³1.5 and p-value 0.05.
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A.

48

B.

Figure 3.10: 23 significant canonical pathways in T1D α cells that mostly associated
to cellular stress response and immune signaling pathways. Graph represents the most
significantly (z-score >2 or <-2) altered canonical pathways in T1D α cells identified by
Ingenuity Pathway Analysis (IPA) ordered by p-value significance. A) Graph based on
predicted pathway activation or inhibition by IPA. (Orange: Activated, Blue: Inhibited).
Ratio refers to number of genes in a given pathway divided by genes that make up the
canonical pathway. B) Stacked bar chart on up and downregulated gene counts on each
pathway. Differential expression of genes used for IPA analysis was based on fold change
cutoff ³1.5 and p-value <0.05.
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Table 3.3: Molecules predicted to be activated or inhibited by IPA’s Upstream Analysis
based on up and downregulated genes in T1D α cells
Upstream
Regulator

log2
(FC)

complex

Predicted
Activation
State
Activated

TCR

complex

Activated

3.128

2.88E-03

PDGF BB

complex

Activated

3.784

1.27E-03

CD40LG
TNF

cytokine
cytokine

Activated
Activated

2.24
6.894

2.14E-02

IFNA2
IL1B

cytokine
cytokine

Activated
Activated

3.006
5.614

6.74E-03

IFNG
IL5

cytokine
cytokine

Activated
Activated

6.235
4.367

5.58E-03

OSM
SPTLC2

cytokine
enzyme

Activated
Inhibited

3.876
-2.425

6.76E-05

CD38
POR

enzyme
enzyme

Activated
Activated

2.624
2.763

1.76E-02

FN1
HRAS

enzyme
enzyme

Activated
Activated

2.112
2.81

1.30E-02

KRAS
P2RY14

enzyme
g-protein coupled
receptor
growth factor
growth factor

Activated
Inhibited

2.515
-3

4.17E-07

Inhibited
Activated

-2.037
2.761

8.49E-03

AGT
TGFB1

growth factor
growth factor

Activated
Activated

2.248
3.107

4.06E-02

HGF
PKD1

growth factor
ion channel

Activated
Inhibited

3.481
-2.623

7.43E-07

PEX5L
ZAP70

ion channel
kinase

Activated
Inhibited

2.219
-2

5.37E-02

MAPK1
EIF2AK2

kinase
kinase

Inhibited
Activated

-2.017
2.927

8.86E-03

EGFR
MAP4K4

kinase
kinase

Activated
Activated

2.066
3.679

1.32E-02

ligand-dependent
nuclear receptor
peptidase

Inhibited

-2.299

5.62E-02

Activated

3.78

5.55E-02

transcription regulator

Inhibited

-2.916

4.15E-02

transcription regulator

Inhibited

-2.571

4.09E-02

NFkB(comp

Molecule Type

Activation
z-score

p-value
of
overlap

5.269

3.19E-02

lex)

BDNF
ANGPT2

PPARA

-0.591

0.636

-1.13

F2
PPARGC1
B
ZEB1

1.186
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1.24E-02
5.82E-03
1.67E-03
2.90E-02
1.59E-02
1.28E-04
3.58E-02

5.40E-02
3.26E-04
2.10E-02
2.01E-02
5.25E-02
7.18E-03

Upstream
Regulator

log2(FC)

Molecule Type

NEUROG3

transcription regulator

Predicted
Activation
State
Inhibited

PPARGC1
A
HNF1A

transcription regulator

Activation
z-score

p-value
of
overlap

-3.886

2.76E-02

Inhibited

-2.101

2.28E-02

transcription regulator

Inhibited

-4.6

1.04E-02

SREBF1
GFI1

transcription regulator
transcription regulator

Inhibited
Inhibited

-4.184
-3.578

8.18E-03

SIRT2
SREBF2

transcription regulator
transcription regulator

Inhibited
Inhibited

-2.714
-3.059

3.10E-05

ID3
FOXL2

transcription regulator
transcription regulator

Activated
Activated

2.5
4.085

4.83E-02

transcription regulator
transcription regulator

Activated
Activated

3.148
2.25

9.71E-03

transcription regulator
transcription regulator

Activated
Activated

2.429
7.245

4.81E-05

transcription regulator
transcription regulator

Activated
Activated

2.077
3.516

1.55E-06

MYCN
CD28

transcription regulator
transmembrane receptor

Activated
Inhibited

5.36
-2.769

1.21E-09

TREM1
OSMR

transmembrane receptor
transmembrane receptor

Activated
Activated

2.688
2.178

3.06E-02

ECSIT
KDM5B

0.739

ATF4
NUPR1

1.054

PDX1
CREB1

-0.734

0.8
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3.41E-03
1.78E-08
1.97E-02
3.50E-04
3.46E-06
1.23E-06
1.13E-02
1.21E-02

A.
NRF2-mediated oxidative
stress response

p38 MAPK
CDC25B
PLA2G6
TAB1
PLA2G12A
RPS6KA2
MAPK13
IL1R2
EEF2K
CREBBP
HSPB1
MAP2K4
MAPK14
MAPKAPK2
MAP3K5
TNFRSF1A
RPS6KB1
IRAK2
MAP2K3
ATF4
IL1RAP
DUSP10
SRF
DDIT3
IL1R1
MKNK2
CREB5
TGFBR2
PLA2G1B

PTPLAD1
CAT
CLPP
AKR
AOX1
SR-BI
c-MAF
FKBP5
MEK5
CCT7
ERK5
SQSTM1
p38MAPK
TXN
GCLC
ASK1
PERK
MRP1
MRP4
ATF4
TRXR1
MRP2
FRA1

-2

-1

0

1

2

3

4

-2

log2 (Fold Change)

MIF Regulated Innate
Immunity
PLA2G6
PLA2G12A
MAP2K4
CD74
NFKB1
NFKBIE
RELA
MAPK8
NFKBIB
NFKBIA
CD14
PLA2G1B

-1

0

1

2

0

1

log2 (Fold Change)

B.

-2

-1

3

4

log2 (Fold Change)
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2

3

4

B cell Receptor Signaling

Production of NO and ROS in
macrophages

VAV3
MAP3K15
PTPN6
PIK3C2B
PIK3R3
TCF3
INPP5F
CAMK2B
AKT3
OCRL
PIK3R1
CAMK2G
EGR1
VAV2
PTEN
RAP1A
ATM
CALM1
PIK3R2
MAPK13
CREBBP
GAB2
NFATC2
MAP2K4
ABL1
MAPK14
MAP3K2
PPP3R1
IRS1
NRAS
MAP3K5
RAP1B
BCL10
PPP3CC
RPS6KB1
MAP3K3
IRS2
MAP2K3
ATF4
NFKB1
NFKBIE
RELA
RAP2B
POU2F2
CFL2
MAP3K8
MAPK8
ETS1
NFKBIB
NFKBIA
CREB5

PPP2R2C
MAP3K15
RHOB
PCYOX1
PTPN6
PIK3C2B
CAT
PIK3R3
PPARA
PRKCI
AKT3
PPP1R11
PIK3R1
PTPA
RAP1A
ATM
PIK3R2
PRKCG
MAPK13
PPM1L
PPP1CA
CREBBP
SERPINA1
PPP1CC
RHOU
PRKCD
MAP2K4
RHOQ
MAPK14
MAP3K2
IRS1
JAK1
MAP3K5
RHOG
RHOF
RAP1B
TNFRSF1A
MAP3K3
IRS2
IRF1
IFNGR1
PRKD1
NFKB1
NFKBIE
RELA
MAP3K8
MAPK8
NFKBIB
NFKBIA

-3

-2

-1

0

1

2

-3

3

-2

-1

0

1

2

3

log2 (Fold Change)

log2 (Fold Change)

Figure 3.11: Gene list in significant canonical pathways from IPA analysis of T1D α
cells associated to A) Cellular stress response B) Immune signaling. Differential
expression of genes used for IPA analysis was based on fold change cutoff ³1.5 and pvalue 0.05.
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A.

B.

Figure 3.12: Proposed model for disrupted glucagon secretion in T1D α cells. A)
Normal α cell function is maintained by islet-enriched transcription factors, which regulate
α cell machinery necessary for glucagon synthesis and secretion (left panel). Altered
expression of transcription factors likely leads to reduced α cell glucagon production,
disrupted calcium homeostasis and electrical activity that results in impaired glucagon
secretion (right panel, green font indicates downregulation). B) Under extreme β cell loss
and systemic hyperglycemia in T1D diabetes, α cells loose expression of their critical
transcriptional regulators which leads to altered expression of their downstream targets and
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results in impaired glucagon secretion.

Gene Expression in T1D Whole Islets Indicated Ongoing Inflammatory Signaling,
Viral response and Apoptosis
We analyzed T1D whole islets from 2 donors compared to 5 normal donors in order to
assess overall transcript level changes in T1D islets by RNA-sequencing (Table 3.1 and
3.2). We prepared mRNA libraries and sequenced all samples from control and T1D whole
islets generating close to 50 million reads per sample. PCA assessed the pairwise
relationship between all whole islet samples from control and T1D showing clusters of
control apart from T1D samples (Figure 3.13). Differential expression was defined as genes
greater than 1.5-fold increased expression in T1D compared to control with p-value cutoff
of 0.05. Comparing the gene expression of whole islets across control and T1D, we found
out of 2433 genes differentially expressed out of which 1125 genes were upregulated and
1308 genes were downregulated (Figure 3.14). Top 20 Gene Ontology (GO) annotations
identified differences in biological processes associated mostly to vasculature, immune
response, extracellular matrix organization and cell adhesion molecules (Figure 3.15,
3.18). In case of Ingenuity Pathway Analysis (IPA), we narrowed the canonical pathways
list by z-score cutoff of ± 2 and p-value less than 0.05 resulting in 16 significant canonical
pathways. These canonical pathways mostly associated to immune response, viral infection
and apoptosis (Figure 3.16). Transcripts of pattern recognition receptors (PRRs) like TLRs
(toll like receptors), IRF family of transcription factors, RIG-1 receptors, cytokine
signaling suggest activation of type 1 interferon pathway that mediates antiviral responses
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and triggering of innate immune system (Figure 3.5, 3.6). This result is in line with previous
report that studied cytokine expression in T1D islets through RT-PCR that showed
association to interferon signaling (Huang, Xiaojian, et al., 1995). Similarly, interferon
associated genes have been observed in peripheral blood of T1D individuals(Reynier et al.
2010) . Furthermore, mouse model studies have demonstrated that Interferon induction
exacerbates T1D whereas inhibiting the IFN receptors improves the disease(Q. Li et al.
2008). These previous finding and our results shows essential involvement of viral
infection in T1D, although unclear whether it is causal or consequence.

In case of apoptosis, there are different mechanisms in which immune signaling prompts β
cell apoptosis that has been discussed through rodent studies. Autoantigen activated CD4+
cells produce IL-2 and IFNg which in turn activates macrophages and cytotoxic CD8+ T
cells to affects β cell death by 3 mechanisms(Figure 3.6): 1)perforin/granzyme pathway,
2) Fas/FasL pathway , 3) IL-1β , TNFα, TNFβ, IFNg activation by macrophages and
cytotoxic CD8+ T cells (Størling and Pociot 2017). Differentially expressed genes in T1D
whole islets did not express any genes related to perforin/granzyme pathway and Fas/FasL
pathway, however, genes downstream to IL-1β, TNFα, TNFβ, IFNg produced by
macrophages and cytotoxic CD8+ T cells were upregulated like STAT1, NF-kB,
TNFAIP3, IRF1, RIP, TRAF2, IL-1R1, MYD88 (Figure 3.17). This suggests Interferon
induced cell death through activation of NF-kB pathway and JAK-STAT pathway to
produce nitric oxide in β cells and induce apoptosis. This result agrees with previous
evidences discussing the role of STAT1and NF-kB in β cell apoptosis (Cnop et al. 2005).
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Figure 3.13: Principal component analysis (PCA) plot shows clustering of whole islet
samples from control (n=6; ages 16-55yrs) and T1D donors (n=2; ages 14yr and 20yr).

Figure 3.14: Volcano plot of differentially expressed genes between control and T1D
Whole Islets (upregulation: red; downregulation: green). Differential expression of genes
was based on fold change cutoff ³1.5 and p-value 0.05.
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Figure 3.15: Top 20 Gene Ontology (GO) annotations from differential expression
gene list between T1D whole islets and control. GO identified biological processes
associated to mostly vasculature, immune response, extracellular matrix organization and
cell adhesion molecules. Bar graph highlights top 20 significant biological processes,
cellular components, and molecular functions identified by Gene Ontology (GO) term
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analysis ordered by p-value significance. Differential expression of genes used for GO
analysis was based on fold change cutoff ³1.5 and p-value 0.05.

A.
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B.

Figure 3.16: 16 significant canonical pathways from IPA mostly associated to immune
response, viral infection and apoptosis. Graph represents most significantly (z-score >2
or <-2) altered canonical pathways in T1D whole islets identified by Ingenuity Pathway
Analysis (IPA) ordered by p-value significance. A. Graph based on predicted pathway
activation or inhibition by IPA. (Orange: Activated, Blue: Inhibited). Ratio refers to
number of genes in a given pathway divided by genes that make up the canonical pathway.
B. Graph based on up and downregulated gene counts on each pathway. Differential
expression of genes used for IPA analysis was based on fold change cutoff ³1.5 and pvalue <0.05.
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Figure 3.17: T1D signaling pathway depicted by IPA showing increased expression of
genes downstream to IFN-g, TNF-α and IL-1β induced macrophages and CD8+
Tcells. (Red: upregulated genes, differential expression of genes used for GO analysis was
based on fold change cutoff ³1.5 and p-value <0.05. Predicted activation of genes by IPA
is shown in light pink)
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Figure 3.18: Gene list from Gene Ontology annotations associated to vascular,
neuronal and cell adhesion. Red: upregulated genes, Green: downregulated genes.
Differential expression of genes used for GO analysis was based on fold change cutoff ³1.5
and p-value 0.05.
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Discussion
Our novel approach of investigating pancreatic tissue and isolated islets from the same
T1D individuals allowed us to comprehensively unravel functional and molecular features.
Our results show that remaining β cells in both recent onset and long standing T1D
individual have near normal insulin secretory function and expresses key transcription
factors, NKX6.1 and PDX1, essential for β cell identity and function. However, abundant
T1D α cells had impaired glucagon secretory function which related to reduction of the
intrinsic control from nuclear regulators ARX, MAFB, and RFX6 (Figure 3.12).
Transcripts of downstream targets controlled by these nuclear regulators which includes
processes for proper glucagon exocytosis had a reduced expression. For example,
components of secretory machineries as potassium and sodium channels, vesicle
trafficking, cAMP signaling had reduced expression suggesting regulatory pathways
associated to proper release of glucagon was impaired (Figure 3.12 A). Interestingly,
altered expression of ARX, MAFB and NKX6.1 was partially resolved when T1D islets
were transplanted into non-diabetogenic environment of immunodeficient Nod-SCIDIL2Rgnull (NSG) mice, however functional human β cells were not present in the T1D
islet graft under proliferation stimulation

(Brissova et al. 2018) which points to

diabetogenic environment possibly being primary factor to drive altered expression of
ARX and MAFB in T1D islets. Nonetheless, such disrupted α cell function in T1D islets
may explain why T1D individuals are susceptibility to hypoglycemia and interventions in
improving the gene expression in α cells can possibly restore proper glucagon regulation.
These results raises interesting question of whether α cell defect is mainly due the diabetic
milieu of hyperglycemia or reduced β cell contact. On the other hand, T1D α cells
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expressed a β cell transcription factor NKX6.1 suggesting possible trans-differentiation of
α- β cell conversion , similar result also reported before in mice under extreme β cell loss
(Brissova et al. 2018). However, absence of β cell increase when T1D islets were
transplanted in non-diabetogenic environment and absence of insulin/glucagon coexpression do not support the trans-differentiation events( Brissova et al. 2018). These
results suggest additional intrinsic factors may be required for α-β cell conversion in T1D
islets. Additionally, investigating canonical pathways altered in T1D α cells pointed to
possible immune signaling and stress response as well pointing to the notion whether α cell
defect is a result of immune attack.
Our analysis collectively showed molecular and functional changes in T1D islets, however,
much is to be understood regarding T1D islets and α cell defect. Further studies would be
required to characterize paracrine interaction between endocrine cells in T1D and
understand whether α cell defect stems from immune attack, loss of β cell contact, reduced
intra-islet insulin or hyperglycemic environment. In case of β cells, understanding intrinsic
heterogeneity in terms of function and proliferation capacity might be next step to explore
trans-differentiation events from non-β cell source for therapeutic approach.
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Chapter 4

Single cell Transcriptomics of Human Pancreatic Islets Using High Throughput
Approach Show Transcriptional Heterogeneity in α and β populations

Introduction
Pancreatic islets dysfunction and hyperglycaemia are the hallmark of Type 1 and Type 2
diabetes(Cnop et al. 2005) but little is known about the pathophysiology of pancreatic islets
in diabetes mellitus. Pancreatic islets are multicellular consisting of various hormone
producing cell types α cells, β cells, d cells, g cells (also called PP cells) and e cells that
secretes glucagon, insulin, somatostatin, pancreatic polypeptide and ghrelin respectively.
Additionally, islet microenvironment comprise dense capillary network through which
endocrine cells are in close contact with vascular endothelial cells (EC) and pericytes that
is crucial to relay blood vessel derived signals. Nerves and immune cells in the
microenvironment also contribute to complex cell to cell interaction with endocrine cells
for proper islet function. Unraveling molecular features in all purified islet cell types that
regulates islet function directly or indirectly is crucial to understand islet dysfunction.

For transcript level expression study in islets, purifying all cell types of islets through
Fluorescence Activated Cell Sort (FACS) approach is challenging. FACS approach depend
on antibodies targeted to cell surface markers or intracellular markers specific to a cell
type. Such specific markers are not available for all islet cell types. Most importantly, β
cell specific markers are still lacking. Additionally, limited quantity of sample material still
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remains a major barrier to purify cell types from young individual and T1D donors. For
cell types with specific markers available and FACS sorting possibilities, such purification
can still be considered biased due to relying on one marker that can possibly lead to missing
rare cell subtypes. Previous studies have shown that islet cell composition vary widely in
normal human islets in contrast to mice( Brissova 2005) and these cell compositions can
vary in diabetic state. Therefore, interpretation of gene expression through regular bulk
population based RNA-sequencing in T1D whole islets has been challenging since the
differences in gene expression compared to normal can stem from cell composition
differences. On top of that, recent evidences revealing different subpopulation within β
cells that contribute to variable β cell phenotype only adds to the islet heterogeneity. For
example, β cell population are known to elicit variability in glucose response, glucose
stimulated insulin expression, proliferative activity and susceptibility to oxidative
damage(Roscioni et al. 2016). Compared to β cells, α cell subpopulation is even more
underexplored.

Single cell RNA sequencing studies have begun to address some of these challenges by not
only being able to segregate all cell types based on transcriptional similarity but have found
distinct subpopulations in β cells (Muraro et al. 2016; Segerstolpe et al. 2016; Baron et al.
2016), whereas, some single cell studies did not find any subpopulations( Wang et al. 2016;
Lawlor et al. 2016; Xin et al. 2016). Some of these differences in subpopulation findings
can originate from limited capture of single cells due to low throughput methods which
possibly misses capturing rare population of cells. To overcome such issue, in this study,
we tested a novel high throughput, droplet-based single-cell RNA sequencing technology,
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ChromiumTM System (10x Genomics), which targets 3’ mRNA digital counting of tens of
thousands of single cells in parallel. We analyzed ~40,575 single cells from pancreatic
islets of three normal adult donors (n=3, age 50-66years) and identified clusters of all
pancreas cell types. Within the β and α cell clusters, we examined whether they consisted
of subpopulation with distinct transcriptional expression. Within the α cell cluster, a small
α cell population had high expression of cell cycle markers suggesting an active cell
division and proliferative cellular state within this α cell subset. In case of

β cell

population, we found a small β subset expressing genes associated with ER stress and
unfolded protein response suggesting that β cells are more susceptible to stress than α cells.
In addition, we analyzed two functionally important transcription factors, MAFA and
MAFB expression in β cell population. We investigated β cell subsets based on expression
of MAFA and MAFB, which are expressed only in a fraction of β cells by histological
analysis( Dai et al. 2012). We focused on transcriptional differences between β cells
expressing either MAFA or MAFB uniquely and β cells expressing none or co-expressing
both MAFA and MAFB. Interestingly, we found β cells express PERK mediated ER stress
response genes variably between MAFA and MAFB expressing β cell populations.

Current therapeutic approach to address functional β cell loss in diabetes mellitus is aimed
at restoring β cell mass though regeneration from existing endogenous β cells or
trandifferentiation from non-β cells to a β cell fate (Tritschler et al. 2017). To this end,
exploring various cellular state and proliferative features of β cell would be valuable to
pursue such regenerative potential. Since α and β cells are transcriptionally very similar,
we search for the same cell cycle markers we identified in α cell subpopulation and found
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them in β cell population as well, although found in very few cells compared to α cells.
Nonetheless, such existence of β cells with replicative potential might possibly contribute
to regenerative approach from endogenous β cells.

Transcriptional differences between healthy donor, even within similar age, can also
contribute to understanding clinical heterogeneity in diabetic state. Hence, we focused on
differences of gene expression in pancreatic islets between healthy donors. We found that
all three donors were transcriptionally very similar and expressed known markers of α and
β cells important for function very similarly. Both subpopulations identified in α and β
cells were present in all three donors. Using 10xGenomics platform, our single cell gene
expression study of pancreatic islets from healthy individuals has profiled a large number
of single cells. Such high throughput approach have enabled defining a comprehensive
transcriptional profile of all pancreatic islet cell types and can be a powerful approach to
determine how these transcriptional profile shifts with age and disease.
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Results

Droplet Based High-throughput Single Cell Capture from Human Pancreatic Islets
For this study, human pancreatic islets were obtained from Integrated Islet Distribution
Program (IIDP) and include three healthy adult organ donors (age ranged 50-66years,
Table 4.1). Primary cultured islets ranged in purity from 48-68% and viability ranged from
70-76% (based on trypan blue stain, See Methods). Analyzing secretory function of islets
from all three donors in a dynamic cell perifusion system, we found that β cell’s insulin
secretory response and α cell’s glucagon secretory response under various stimulants were
intact (Figure 4.1B) and comparable to profile of control subjects in Figure 3.3. Each donor
samples were processed with 3 technical replicates for subsequent single cell library
generation using Chromium™ Single Cell 3’Library Kit v2 from 10xGenomics. 40,075
single cells were captured after combining single cells from all three donors and ~6billion
reads generated in total using Illumina Hiseq platform. Cells captured per donor, mean
reads per cells, median genes and transcript per cell are summarized in Table 4.2. Cell
Ranger software suite from 10x Genomics (https://software.10xgenomics.com/singlecell/overview/welcome) was used for sample demultiplexing, barcode processing and
transcript quantification. Resulting gene-cell matrix was further analyzed using R package
Seurat version 2.2(Methods). Initial filtering of low quality cells was done through Seurat
(Methods). Remaining 26,048 cells post QC filtering were further analyzed for cell type
annotation.
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A.

B.

Figure 4.1: Schematic of experimental workflow of single cell isolation from
pancreatic islets. Islets had intact hormone secretory pattern. A) Live primary whole
islets from three human pancreas donors were collected and trypsin dissociated. After
viability and cell counts, cells from each donor were loaded to 10x Chromium chips to
target 10,000 cells from each well of the chip. Subsequent single cell libraries were
generated as per 10x Genomics protocol for single cell gene expression. B) Insulin and
glucagon secretion was assessed in islets isolated from donors (n=3; ages 50-66years)
simultaneously; and normalized to overall islet cell volume (expressed as islet
equivalents, IEQs); G 5.6 – 5.6 mM glucose, G 16.7 – 16.7 mM glucose, G 16.7 + IBMX
100 – 16.7 mM glucose + 100 µM isobutylmethylxanthine (IBMX), G1.7 + Epi 1 – 1.7
mM glucose + 1 µM epinephrine, KCl 20 – 20 mM potassium chloride.
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Table 4.1: Demography of pancreatic islet donors for single cell RNA-sequencing
Samples Age

Sex

BMI

Ethnicity

Donor1

50

Male

22.4

White

Islet
Purity
68%

Cause of
Death
Stroke

Donor2

59

Female

32.3

White

56%

Stroke

Donor3

66

Female

18.5

Unknown

48%

Stroke

Table 4.2: Single cell library sequencing metrics of all donor samples processed for
single cell RNA-sequencing

Sample
Type

Viability
(%)

Targeted
number
of cells

Estimated
Number
of Cells

Mean
Reads
per Cell

Median
Genes
per Cell

Median
Transcript per
Cell

Donor1

72

10,000

6,374

145,773

3,221

13,390

Donor1

72

10,000

3,790

131,995

3,666

15,104

Donor2

76

10,000

4,845

205,093

3,461

13,864

Donor2

76

10,000

5,051

180,728

3,299

12,708

Donor2

76

10,000

9,129

71,528

2,191

7,041

Donor3

70

10,000

3,790

131,995

3,666

15,104

Donor3

70

10,000

3,906

229,626

3,960

16,578

Donor3

70

10,000

3,690

240,527

3,695

14,386

Total
Cells
per
Donor

Number of
Reads

10,164

929,157,585
500,262,351
993,679,252

19,025

912,858,501
652,984,236
500,262,351

11386

896,920,046
887,544,831

Note: One of the technical replicate of Donor 1 failed single cell isolation in chromium system
due to microfluidic channel clogging issues. Therefore, two technical replicate sample were
included for Donor 1.
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Pancreatic Cell Type Annotation
In order to identify all cell types, single cells captured from all three donors were combined
and clustered using graph based clustering approach implemented by Seurat and further
visualized by t-distributed stochastic neighbor embedding (t-SNE). We obtained 10
clusters of cells (Figure 4.2A) and each cluster were identified for a cell type by overlaying
key pancreatic cell type gene markers on the clusters (insulin-INS for β cells, glucagonGCG for α cells, somatostatin-SST for d cells, pancreatic polypeptide-PPY for g cells,
ghrelin-GHRL for e cells, PRSS1 for Acinar cells, PECAM1 for endothelial cells, COL1A1
for mesenchymal and KRT19 for Ductal cells). As a result, clustering of cells was primarily
based on cell types (Figure 4.2B, 4.2C). Principal component analysis on all cells also
showed cells clustered predominantly by cell types (Figure 4.2D). However, in contrast to
non-endocrine population, endocrine cluster expressing INS, GCG and SST was driven by
donor differences (Figure 4.2E). Hence, endocrine cell subset was re-clustered and donor
effect adjusted by Seurat and as a result, we found 8 clusters of cells within endocrine
population without donor effect (Figure 4.3A and Figure 4.3D). Overlay of gene markers
INS, GCG, SST, PPY (Figure 4.3C) in generated clusters and combining clusters that
expressed same gene marker, we were able to identify clusters of α, β and d/ g/e (SST, PP
and GHRL genes were expressed in same cluster) respectively (Figure 4.3B). Endocrine
cell subset did not cluster based on technical replicates suggesting clusters were not driven
by technical factors (Figure 4.3E). Identity of annotated α, β, and d/ g clusters were further
confirmed by expression of gene markers other than hormones (Figure 4.3F). All samples
were processed in single batch so batch effect analysis was not necessary. In summary, all
pancreatic cell types were identified from the clusters generated based. Pancreatic cell
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types composition was α=57%, β=26%, d/g =4%, Ductal=4%, Mesenchymal=4%,
Acinar=2%, Endothelial=2% and Immune=1%. Cell type composition in each donor were
variable with higher α cell population compared to β cells. Higher α cell population was
also observed in Segerstolpe et al. but their study on immunohistochemistry staining of
insulin and glucagon in non-dissociated tissue did not show high α to β cell ratio. This
suggests the possibility of β cell loss during cell dissociation process in our study, therefore
the cell composition might not reflect true biological ratios.
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Figure 4.2: Visualization of pancreatic cell type using t-SNE. A) Each clusters of single
cells (each dot) generated are shown by colors and numbers B) Clusters of cells where each
color represents identified pancreatic cell type and number of cells included in each cell
type is shown in brackets. C) Gene markers of all cell types (INS for β cells, GCG for α
cells, SST for d cells, PPY for g cells, GHRL for e cells, PRSS1 for Acinar cells, PECAM1
for endothelial cells, COL1A1 for mesenchymal and KRT19 for Ductal cells) overlapping
clusters D) Principal component analysis of single cells colored by cell types. E) Clusters
of cells where each color represents donors.

76

A.

B.

C.

77

D.

E.

F.

78

G.

Pancreas Cell Type Composition
100%
90%
80%

%cells

70%
60%
50%
40%
30%
20%
10%
0%

Donor 1
α

β

δ/γ

Ductal

Donor 2
Mesenchymal

Acinar

Donor 3
Endothelial

Immune

Figure 4.3: Visualization of cell types identified in endocrine subset using t-SNE. A)
Clusters of single cells (each dot) from endocrine subset where each color represents
clusters B) Clusters of endocrine cells where each color represents endocrine cell types and
number of cells included in each cell type is shown in brackets. C) Gene markers of all
endocrine cell types (INS for β cell, GCG for α cells, SST for d cells and PPY for g and
GHRL for e cells) overlapping generated clusters D) Clusters of endocrine cells where each
color represents donors. E) Clusters of endocrine cells where each color represents
technical replicates from three donor. F) Dotplot showing expression of α cell, β cell and
d cell specific gene markers where color represents average expression level and size of
the dot represent percentage of cells expressing the gene in each cluster. G) Bar graph
showing percentage of cells in each cell type for all donors.

Unraveling β cell Subpopulation from Human Endocrine Cells
9 clusters of β cells were identified out of 6808 β cells (Figure 4.4A). In order to find
features of clusters in an unbiased approach, we measured differentially expressed gene in
each cluster in comparison to all clusters and repeated for each cluster. Differentially

79

expressed genes between clusters showed increased expression (more than log 1.5-fold) of
genes associated to ER stress response and unfolded protein response (expressed in cluster
7 that contained 138 cells, Figure 4.4B). β cell subpopulation relating to ER stress and
unfolded protein response(UPR) has also been reported in previous studies in (Muraro et
al. 2016) and (Muraro et al. 2016). Due to insulin synthesis load, β cells are known to
commonly involve in ER stress pathway for proper processing of protein translation and
folding by engaging molecular chaperones through unfolded protein response, whereas
sometimes initiate apoptosis if ER stress is incessant (Eizirik, Cardozo, and Cnop 2018).
Additionally, previous evidences show chronic ER stress and UPR involvement
contributes to β cell dysfunction and β cell death but whether ER stress is a major
contributor to disease onset is still debatable(Sharma et al. 2015; Zeng et al. 2017).
Interestingly, active UPR mechanism in β cells has recently been associated sensing insulin
level and regulate β cell proliferation (Zhang et al. 2005; Artner et al. 2006, 2010).
Therefore, it would be of interest to understand why only a small β cell subset engage in
active in ER stress and UPR mechanism and whether they possess better insulin sensing
and proliferative feature than rest of the β cell. Only a small β cell subset (<1%) expressed
cell cycle related mRNA (Figure 4.4 E). This suggests that a small population of β cells
still possibly replicate. However, β cell subset with cell cycle gene markers did not align
with β cell clusters generated in Figure 4.4A, which suggests factors other than cellular
state drives the clustering (Figure 4.4E). Also, further research would be required to rule
out influence of pancreatic islet isolation process and cell dissociation process carried out
prior to single cell isolation implicating ER stress to β cells. However, even if it is a post
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isolation influence, it would be essential to understand why only a small β cell subset
respond to such procedures.

β cell Subsets Expressing MAFA and MAFB Genes Depict Variable Transcriptional
Feature
Leucine zipper transcription factors MAFA and MAFB regulates insulin and glucagon
respectively and have significant role in β cell development and function(Zhang et al. 2005;
Artner et al. 2006, 2010). Previous studies in mouse islets show a unique temporal
expression of MAFA and MAFB during pancreatic development. MAFA is required for
maintaining β cell maturation state and function whereas MAFB, primarily expressed in α
cells, is also transiently expressed during β cell early development (Dai et al. 2012).
However, recently, MAFB was also shown to express in mature β cells in humans (Dai et
al. 2012). Immunohistochemistry staining of MAFA and MAFB cannot distinguish their
co-expression in pancreatic islet tissues. It remains unclear whether there are β cells that
co-localize MAFA and MAFB or what are the consequences of variable expression of these
transcription factors. Hence, we investigated β cell subset based on 1) MAFA expressing
β cells (MAFA+) 2) MAFB expressing β cells(MAFB+) 3) MAFA and MAFB coexpressing
β cells (MAFA+ and MAFB+) and 4) MAFA and MAFB absent β cells (MAFA- and
MAFB-). We found all 4 population in β cells (Figure 4.5A) and these 4 β subsets did not
overlap with the initial 9 clusters of β cells generated in Figure 4.4A. To evaluate the
differences between MAFA+ and MAFB+ β cell population, we analyzed differentially
expressed genes between them and associated biological processes from Gene Ontology
analysis. We found that MAFA+ β cells differentially expressed genes that is essential for
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β cell function (INS, IGFBP5, TFF3) compared to MAFB+ β cells whereas MAFB+ β cells
differentially expressed genes associated to PERK mediated ER stress and UPR
(HERPUD1, DDIT3, HSPA5) compared to MAFA+ β cells (Figure 4.5B, C). This result
shows variable feature of β cells expressing MAFA compared to MAFB. Additionally,
differential expression of genes in MAFA+ and MAFB+ compared to MAFA- and MAFBshowed similar differences in expression of ER stress related genes. MAFA- and MAFBβ cell population differentially expressed ER stress genes compared to MAFA+ and
MAFB+ β cell population (Figure 4.5 D, E). These results suggest that MAFA+ β cell
population is possibly dedicated to maintaining maturity and function whereas MAFB+ as
well as MAFA- and MAFB- cells contribute in maintaining ER homeostasis. MAFA- and
MAFB- β cell population can also stem from lack of MAFA and MAFB transcript capture
due to technical factors. However, this highlights an important β cell feature where
maintaining functional features do not align with same β cells that is dedicated to
maintaining ER homeostasis. This notion is supported by our finding where β cell
subpopulation (cluster 7 in Figure 4.4B) expressing high ER stress genes had lower
expression of β cell functional genes (Figure 4.4 D).

82

A.

B.

ER stress and UPR genes

C.

83
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Figure 4.4: β cells subpopulation express variable transcriptional features. A) Clusters
generated in β cell population shown by colors and numbers B) Heatmap of differentially
expressed genes between clusters (threshold applied were average log fold change >1.5
and p-value less than 0.05) C) Dotplot showing expression of ER stress genes and β
functional genes among β cell clusters where color represents average expression level and
size of the dot represent percentage of cells expressing the gene in each cluster. D)
ScatterPlot of average gene expression of Insulin (INS) and cell cycle related genes
(TOP2A, MKI67,CDK1, CENPF, PTTG1, UBE2C) across all single cells from β cell
subset. Cell are colored by β cell cluster generated in figure 4.4A. Number of cells above
each scatter plot represent number of cells expressing both insulin and cell cycle genes.

84

A.

B.
Differential expression of genes in MAFB+ β cells
population compared to MAFA+ β cell population
MAFA
MTRNR2L8
TFF3
SPP1
FXYD2
IGFBP5
REG1A
MEG3
MTRNR2L12
FOS
INS
GSN
PLK2
HLA-B
NEUROD1
SNRPD1
TPI1
PTP4A3
SSX2IP
SNRPB
CITED2
TMEM176B
CFL1
DDIT3
B2M
S100A10
FTL
GLS
ACTG1
CYSTM1
CRYBA2
PALLD
HERPUD1
GADD45G
CHGB
VGF
SLC7A2
SERPINA1
RGS4
HSPA5
HSPB1
RBP4
MAFB

-1

-0.5

0

0.5

log (Fold Change)

85

1

1.5

2

C.

86

D.
Differential expression of genes in MAFA+
and MAFB+ β cells compared to MAFAand MAFB- β cells
HSPA5
HERPUD1
SPP1
VIM
HSP90B1
DDIT3
HSPB1
MT2A
PDIA4
MANF
SCG5
CHGA
FABP5
PDIA3
CHGB
NUCB2
SERPINA1
VIMP
DNAJB9
TNFRSF12A
SPINK1
NEUROD1
CCNI
RPS10
RPLP2
RPS23
MT-ND1
RPS11
MT-CO2
FTH1
MEIS2
ROBO2
IDS
PCSK1
PDX1
HADH
RPS18
ERO1B
RBP4
METRN
FAM159B
C12orf75
ABCC8
MT-CO3
RPL7A
RPS2
NPY
HIST1H4C
PPP1R1A
ID1
RPS28
PLCXD3
MT-CO1
RPS3
RPL37A
SAMD11
G6PC2
RPL23
PAX6
SLC30A8
IAPP
MAFA
MAFB

-1.5

-1

-0.5

0

0.5

log (Fold Change)

87

1

1.5

2

E.

Figure 4.5 MAFA and MAFB expression in β cell subset depict variable
transcriptional features. A) Scatter plot of MAFA and MAFB gene expression across
single cells of β cell subset. Colors represent β cell clusters generated in figure 4.4A.
MAFA+, MAFB+, MAFA+ MAFB+, MAFA- MAFB- population were subdivided based on
their expression of MAFA and MAFB above and below expression of 0.25 B) Differential
expression of genes in MAFB+ β cells population compared to MAFA+ β cell population.
C) Gene ontology analysis (Biological Processes) from differently expressed genes
between MAFB+ compared to MAFA+ β cell population. D) Differential expression of
genes in MAFA+ MAFB+ β cell population compared to MAFA- MAFB- β cell population.
E) Gene ontology analysis (Biological Processes) from differently expressed genes
between MAFA+ MAFB+ compared to MAFA- MAFB- β cell population.

Unraveling α cell Subpopulation and Cellular State from Human Endocrine Cells
Unbiased clustering of α cell population identified 8 clusters out of total 14,967 α cells
(Figure 4.6A). In order to find feature of all clusters in an unbiased approach, we measured
differentially expressed gene in each cluster in comparison to all clusters. Interestingly,
differentially expression and GO term analysis of genes in cluster 8 of α cell subset showed
expression of genes associated to cell cycle pathway and proliferation (Figure 4.6B, 4.6C).
This result is consistent with recent report from single cell mass cytometry analysis,
showing α cell comprising high basal replication rate and high mitogen response compared
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to other cell types in both normal and T2D tissue(Segerstolpe et al. 2016). Additionally,
high expression of TOP2A, BIRC5, CDK1, MKI67 proliferation associated marker in 12
α cells was also observed in (Segerstolpe et al. 2016). We confirmed the proliferative α cell
subset with larger sample size (103 cells) and showed 375 genes differentially expressed
in proliferative α cell subset that can be potential therapeutic cues to leverage for possibly
islet cell regeneration purposes. We show top 30 out of 375 in Figure 4.6C that mostly
associated to cell cycle regulation (Full list in Appendix). Future research on pathways
activated in proliferative α cell subset may highlight mechanism of proliferation
differences between α and β cells. Rest of the α cell clusters seemed homogenous in terms
of α cell enriched functional genes (GCG, ARX, MAFB, TM4SF4)(data not shown) .
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C.
Top 30 Upregulated genes in Cluster 8
of α cell population
CDKN2D
HMGB1
SMC4
ATAD2
BIRC5
CCDC34
HMMR
DEK
CKAP2
PTMA
CKS1B
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Figure 4.6: α cells subpopulation reveal variable cellular state. A) Clusters generated
in α cell population shown by different colors and numbers. B) Violin plot showing
expression of genes associated to cell cycle and proliferation expressed specifically in
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cluster 8 of α cells. Expression is showed in log space. C) Top 30 Upregulated genes in
Cluster 8 of α cell population.

Human Pancreatic Islets are Transcriptionally Very Similar between Donors
To establish donor differences, we compared average expression of genes between donors
which showed that all three donors were highly correlated (Pearson correlation 0.96-0.99)
(Figure 4.7A). Comparing β cell and α cell population in each donor also showed high
correlation (Pearson correlation 0.96-0.99) (Figure 4.7B, C). On a transcriptional level,
INS and GCG transcript expression were relatively similar between all donors and so was
β cell specific and α cell specific gene markers important for function (Figure 4.7C, D).
Based on above results, similar transcriptome were observed in similarly aged adult donors
of this study.

A.
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Figure 4.7 Human pancreatic islets are transcriptionally very similar between donors.
A) Scatter plot of average expression of all genes shown between donors. Pearson
correlation is shown above the plot. B) Scatter plot of average expression of all genes in β
cell population between donors. Pearson correlation is shown above the plot C) Scatter plot
of average expression of all genes in α cell population between donors. Pearson correlation
is shown above the plot D) Violin plot showing distribution of cells expressing insulin
(INS) and β cell specific genes important for function among β cell population of all donors
E) Violin plot showing distribution of cells expressing of Glucagon (GCG) and α cell
specific genes important for function among α cell population of all donors. All expression
levels are showed in log space.

Discussion
Using ChromiumTM system for single cell RNA-Sequencing, we were able to apply a novel
high throughput approach to profile a large single cell population (~40,075 cells) in human
pancreatic islets. This approach allowed us to explore α and β cell population in a larger
scale and showed their intrinsic transcriptional differences. In case of β cells, we found a
small subpopulation (2%) highly expressing genes associated with ER stress and UPR. A
recent study shows ER stress in β cells is known to increase cytosolic calcium that initiate
an abnormal post translation modification(PTM) of proteins that predisposes β cells to
immunogenicity causing T1D (Marré et al. 2017). In this regard, normal physiology of ER
homeostasis found in a small β cell subpopulation as seen in our study of normal donors
makes β cells vulnerable to immunogenecity as oppose to α cells that do not express ER
stress as much. We further investigated two important transcription factors, MAFA and
MAFB required for β cell development and function which have unique temporal
expression in mice but both MAFA and MAFB are expressed in human even in adult stage.
In adult donors used for this study, we showed presence of not just β cell subpopulation
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expressing MAFA and MAFB uniquely, but also β cells co-expressing both and expressing
none. This shows that the temporal dynamics of MAFA and MAFB expression seen in
mice, on an mRNA expression level, do not occur in humans. Interestingly, our results also
show expression of MAFB+ β cells has more expression of ER stress and UPR genes and
MAFA+ β cells contributed mostly to β cell function (Figure 4.5) which suggests MAFB
in mature β cells is possibly dedicated to maintaining ER homeostasis as oppose to
supporting β cell function. This result might suggest maintaining ER homeostasis is
mutually exclusive to maintaining β cell function which is supported by our results showing
β cell subpopulation expressing ER stress and UPR also had reduced expression of genes
associated to function (Figure 4.4D).

Presently, cues to enhance β cell proliferation from residual endogenous β cells in diabetic
tissue is of great therapeutic research focus. Mouse studies have shown postnatal β cells in
mice have high proliferative cells but are known to reduce very early on and is minimal in
adult state (Qiu et al. 2017). Less than 1% β cells in adult donors in our study expressed
transcripts associated to cell cycle including MKI67 that encodes for proliferation marker
protein Ki67, agreeing with minimal proliferative state as in mice. However, such β cells
with proliferation marker were not detected in previous single cell studies. We argue that
profiling single cells at large scale from islets revealed these rare β cells with proliferation
markers. However, more α cells than β cells expressed transcript associated with cell cycle
genes (Figure 4.6B, C). By revealing numerous genes expressed in clusters of proliferative
α cells should provide more targets to assist for trans-differentiation purposes from α cell
to β cells.
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Similar aged donor differences are essential to explore for further study on clinical disease
heterogeneity in diabetes mellitus, hence we were also interested in subtle donor specific
differences in transcriptional level. Overall, single cell transcriptional profiles highly
correlated across three donors suggesting transcriptional similarity between donors. This
was supported by high correlation of overall β cell and α cell populations between donors
as well as similarly expressed β cells and α cell functional genes.
Our results from comprehensive transcriptomic profile of single cells from pancreatic islets
by a high throughput approach identified α and β cell subpopulation with functional
heterogeneity which should be valuable for further inquiries of these subpopulation in
variably aged and diabetic tissue.
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Chapter 5
Conclusion and Future Directions
One of the main objective of the dissertation was to define functional and molecular
characteristics of α and β cells from pancreatic islets of individuals from T1D and we did
so by novel approach of studying islets and pancreas from same T1D individual. Little was
known about the functional state of the remaining β cells from T1D patients and how some
of them resist the immune attack for years in long standing patients. Our study reveal that
β cell secretory function appear to be normal in T1D individual and expression of β cell
specific transcription factors in transcript and protein level unaltered suggesting that T1D
pathogenesis is possibly driven by β cell loss rather than loss of function.
These results lead to important questions like:
1. Are the remnant β cells with normal secretory function, resistant β cell subset that
escapes immune attack?
2. Are they new β cells regenerated from pancreatic progenitors (neogenesis)?
3. Are result of replication from existing β cells or transdifferentiated from non β cell
source like acinar, duct, α and d cells?

On the other hand, loss of α cell’s lack of response to hypoglycemia in T1D was known
previously but our results further the understanding of α cell dysfunction by showing
impaired glucagon secretory capacity, reduced expression of major nuclear transcription
factors (RFX6, ARX and MAFB) important for α cell function and expression of a β cell
marker (NKX6.1) in both transcript and protein level. Expression of a β cell marker in α
cell would suggest trans-differentiation events occurring but absence of polyhormonal cell
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(insulin and glucagon positive cells) and no change in insulin positive cells when T1D
islets were transplanted to nondiabetic environment(Santin and Eizirik 2013) suggest
additional stimuli must be required for trans-differentiation. Lineage tracing experiments
in α cell might determine α cell plasticity in this regard. Additionally, downstream targets
of these very altered transcription factors, like the components associated to ion channels
imperative for proper glucagon secretion from the cell had reduced expression in transcript
level. Therefore, we proposed a model for α cell dysfunction in T1D that suggests altered
expression of these nuclear transcription factors likely leads to reduced α cell glucagon
production, disrupted electrical activity and altered calcium homeostasis that results in
impaired glucagon secretion. Additionally, altered expression of ARX and MAFB were
restored in α cells when T1D islets were transplanted to a nondiabetic environment (M.
Brissova 2005) suggesting intervention in improving α cell dysfunction and glucagon
secretion can possibly halt disease progression. However, this therapeutic approach in
improving glucagon secretion would require understanding further important questions
like:
1. Is the α cell defect result of immune attack?
2. Is the α cell defect simply due to loss of β cell contact or other factors in diabetic
milieu?

Our molecular and functional profiling study of pancreas and islets from T1D does have
limitations mainly due to low sample size. However, this study is first to characterize islets
and pancreas from the same donor in midst of organ scarcity and the utility of this approach
have revealed important understanding about remaining β and α cells in T1D not known
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before and instigate further important questions to pursue as future study.

Second goal of the dissertation was to optimize a high throughput method for single cell
RNA-sequencing and demonstrate its utility in unraveling rare populations in α and β cells.
Only recently have we learned cell-cell variations in tissues and in context of β cell, we are
recently trying to understand whether β cell’s ability to sense rapidly changing
physiological cues or vulnerability to immune attack possibly comes from heterogeneous
functional variations within β cells. Single cell RNA-sequencing have begun to unravel
cell-cell variation in β cells to understand the heterogeneity, however, current low
throughput methods and profiling limited number of cells have possibly missed rare
populations in β cells. We applied a high throughput droplet-based technology to profile
~40,075 single cells from pancreatic islets and subset 6808 β cells to identify
subpopulations that have variation in gene expression associated to ER stress. We found
~2% β cells characterized by genes associated to ER stress which has been associated with
predisposing β cells to immunogenicity in T1D as well as possible properties of
proliferative β cells (Reynier et al. 2010). Further in situ study is warranted to understand
the role of such β cell subpopulation. Interestingly, same ER stress markers were expressed
more by MAFB positive β cells when compared to MAFA positive β cells. Further pursuing
MAFB to ER stress mRNA through spatial resolution would be good direction for future
research. We also found few β cells expressing proliferation markers not reported before
in previous single cell RNAseq studies that demonstrates the value of utilizing high
throughput approach in profiling single cells. On the other hand, studying 14,967 α cells,
~2% of α cell subset was characterized by many genes associated to cell cycle and
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proliferation suggesting proliferative capacity of α cells still exist in adult donor pancreas
and can be leveraged for trans-differentiation purposes. Lastly, we did not find donor
differences on transcriptional level based on analyzing average expression of all genes
between donors and key marker genes being expressed similarly between all three donors.
In summary, our high throughput single cell approach was able to annotate all cell types of
islets and further reveal α and β subpopulation characteristics that adds to the knowledge
of intrinsic properties of α and β cells in adult pancreatic islets from healthy individuals.
Single cell RNA-sequencing profile of more donors would be important to reproduce the
outcome observed in this study and moreover, similar single cell approach in T1D donors
can possibly reveal how these α and β subpopulations are implicated in diabetic state as
well as identify pathways altered in T1D that may lead to potential drug targets. To date,
only one T1D donor have been assessed through single cell approach due to limited T1D
tissue availability. As a future study, to overcome such sample limitation, we can leverage
already available the bulk RNA-sequencing data from T1D patients by deconvolving
approach. Such approach can correct for cell composition differences in healthy as well as
diseased tissue to investigate differential expression without cell composition bias. This
approach has been applied in Baron et al. 2016 for T2D. On a technical side, single cell
data preprocess and strategies to resolve technical noise is not standardized and novel
approaches to address them are still emerging. An analytical pipeline that reproduce results
across larger sample size is also warranted as a future study.
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APPENDIX

A1. Sequencing and alignment metrics for RNA-sequencing of whole islets and
sorted α cells from Normal and T1D individuals
Tissue
Type

Age
(yrs)

Donor

Gender

Whole
islets
Whole
islets
Whole
islets
Whole
islets
Whole
islets
Whole
islets
Whole
islets
Whole
islets

20

T1D

M

α
cells
α
cells
α
cells
α
cells
α
cells
α
cells
α
cells
α
cells

14
24

T1D
Normal

% >=
Q30

QScore

95.07%

35.55

Alignment
%
88.10%

95.24%

35.59

88.40%

95.39%

35.62

90.20%

95.70%

35.68

90.00%

100,364,696
98,845,844

95.21%

35.58

90.10%

48,417,668

95.60%

35.76

86.60%

Total reads

PF reads

111,841,332

107,980,317

106,230,706

102,651,106
99,703,341

F
M
103,122,226

26

Normal

F

55

Normal

M

103,651,170
16

Normal

M

102,268,276
50,334,683

35

Normal

F

48,535,103

46,821,138

95.40%

35.73

83.20%

50

Normal

M

50,428,795

48,747,411

95.51%

35.75

88.20%

14

T1D

F

96,925,923

95.03%

35.51

82.20%

100,398,126
30

T1D

M

24

T1D

M

49

Normal

F

26

Normal

F

55

Normal

M

98,262,618

95.14%

35.56

79.70%

102,260,768
155,582,279

139,624,591

91.18%

34.95

86.20%

95.13%

35.56

85.70%

120,933,336
99,400,126

116,565,413
95,801,712

95.32%

35.6

88.50%

95.62%

35.66

88.90%

105,140,507
49,816,832

94.91%

35.63

56.90%

49,388,247

95.39%

35.73

86.10%

35

Normal

F

108,596,424
52,122,987

50

Normal

M

51,154,804
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